| Variable | Overall, N = 540,8381 | *NSQIP Table | p-value2 | |
|---|---|---|---|---|
| female, N = 324,2531 | male, N = 216,5851 | |||
| PRNCPTX | ||||
| ABDL LMPHADEC REG CELIAC GSTR PORTAL PRIPNCRTC | 90 (<0.1%) | 46 (<0.1%) | 44 (<0.1%) | |
| ABLTJ OPN 1/> LVR TUM CRYOSURG | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| ABLTJ OPN 1/> LVR TUM RF | 221 (<0.1%) | 83 (<0.1%) | 138 (<0.1%) | |
| ACETABULOPLASTY RESECTION FEMORAL HEAD | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| ADENOIDECTOMY PRIMARY AGE 12/> | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ADJNT TIS TRNSFR/REARGMT ANY AREA 30.1-60 SQ CM | 93 (<0.1%) | 51 (<0.1%) | 42 (<0.1%) | |
| ADJT TIS TRNSFR/REARGMT DEFEC EA ADDL 30 SQCM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ADJT TIS TRNSFR/REARGMT DEFEC EA ADDL 30 SQCM/< | 8 (<0.1%) | 5 (<0.1%) | 3 (<0.1%) | |
| ADRENALECTOMY EXPL W/EXC RETROPERTINEAL TUMOR | 139 (<0.1%) | 71 (<0.1%) | 68 (<0.1%) | |
| ADRENALECTOMY W/EXPL W/WO BX ABDL/LMBR/DRSAL SPX | 405 (<0.1%) | 214 (<0.1%) | 191 (<0.1%) | |
| AGMNTJ MNDBLR BODY/ANGLE PROSTHETIC MATERIAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| AMP ANKLE-MALLI TIBFIB W/PLSTC CLSR&RESCJ NRV | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| AMP F/TH 1/2 JT/PHALANX W/NEURECT LOCAL FLAP | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| AMP F/TH 1/2 JT/PHALANX W/NEURECT W/DIR CLSR | 5 (<0.1%) | 0 (0%) | 5 (<0.1%) | |
| ANAST INTRAHEPATC DUCTS & GI TRACT | 39 (<0.1%) | 18 (<0.1%) | 21 (<0.1%) | |
| ANAST ROUX-EN-Y INTRAHEPATC BILIARY DUCTS & GI | 280 (<0.1%) | 155 (<0.1%) | 125 (<0.1%) | |
| ANAST ROUX-EN-Y XTRHEPATC BILIARY DUCTS & GI | 600 (0.1%) | 295 (<0.1%) | 305 (0.1%) | |
| ANAST XTRHEPATC BILIARY DUCTS & GI TRACT | 176 (<0.1%) | 105 (<0.1%) | 71 (<0.1%) | |
| ANOPLASTY PLASTIC OPERATION STRICTURE ADULT | 23 (<0.1%) | 13 (<0.1%) | 10 (<0.1%) | |
| ANORECTAL MYOMECTOMY | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| ANTERIOR COLPORRAPHY RPR CYSTOCELE W/CYSTO | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| ANTERIOR INSTRUMENTATION 2-3 VERTEBRAL SEGMENTS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| APP SKN SUB GRFT T/A/L AREA/100SQ CM /<1ST 25 | 22 (<0.1%) | 10 (<0.1%) | 12 (<0.1%) | |
| APP SKN SUB GRFT T/A/L AREA/100SQ CM EA ADL 25SC | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| APP SKN SUB GRFT T/A/L AREA>/=100SCM ADL 100SQCM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| APP SKN SUBGRFT T/A/L AREA/100SQ CM 1ST 100SQ CM | 23 (<0.1%) | 9 (<0.1%) | 14 (<0.1%) | |
| APPENDEC INDICATED PURPOSE OTH MAJOR PX NOT SPX | 23 (<0.1%) | 12 (<0.1%) | 11 (<0.1%) | |
| APPENDEC RPTD APPENDIX ABSC/PRITONITIS | 111 (<0.1%) | 55 (<0.1%) | 56 (<0.1%) | |
| APPENDECTOMY | 520 (<0.1%) | 274 (<0.1%) | 246 (0.1%) | |
| ARREST EPIPHYSEAL TIBIA & FIBULA PROXIMAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHDSIS POST/POSTEROLATRL/POSTINTERBODY LUMBAR | 28 (<0.1%) | 15 (<0.1%) | 13 (<0.1%) | |
| ARTHRD ANT INTERBODY DECOMPRESS CERVICAL BELW C2 | 61 (<0.1%) | 29 (<0.1%) | 32 (<0.1%) | |
| ARTHRD ANT MIN DISCECT INTERBODY CERV BELOW C2 | 10 (<0.1%) | 7 (<0.1%) | 3 (<0.1%) | |
| ARTHRD ANT TRANSORL/XTRORAL C1-C2 W/WO EXC ODNTD | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRODESIS ANTERIOR INTERBODY EA ADDL NTRSPC | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| ARTHRODESIS ANTERIOR INTERBODY LUMBAR | 59 (<0.1%) | 27 (<0.1%) | 32 (<0.1%) | |
| ARTHRODESIS KNEE ANY TECHNIQUE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRODESIS LATERAL EXTRACAVITARY LUMBAR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHRODESIS POSTERIOR ATLAS-AXIS C1-C2 | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRODESIS POSTERIOR CRANIOCERVICAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHRODESIS POSTERIOR INTERBODY LUMBAR | 21 (<0.1%) | 9 (<0.1%) | 12 (<0.1%) | |
| ARTHRODESIS POSTERIOR SPINAL DFRM 7-12 VRT SEG | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRODESIS POSTERIOR/POSTEROLATERAL EA ADDL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRODESIS POSTERIOR/POSTEROLATERAL LUMBAR | 21 (<0.1%) | 9 (<0.1%) | 12 (<0.1%) | |
| ARTHRODESIS POSTERIOR/POSTEROLATERAL THORACIC | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| ARTHRODESIS PRESACRAL INTRBDY W/INSTRUMENT L5-S1 | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| ARTHRODESIS PST/PSTLAT CERVICAL BELW C2 SGM | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| ARTHROPLASTY ANKLE REVISION TOTAL ANKLE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| ARTHROPLASTY ANKLE W/IMPLANT | 5 (<0.1%) | 1 (<0.1%) | 4 (<0.1%) | |
| ARTHROPLASTY FEM CONDYLES/TIBIAL PLATEAU KNEE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHROPLASTY GLENOHUMERAL JOINT TOTAL SHOULDER | 39 (<0.1%) | 23 (<0.1%) | 16 (<0.1%) | |
| ARTHROPLASTY GLENOHUMRL JT HEMIARTHROPLASTY | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| ARTHROPLASTY INTERPHALANGEAL JOINT EACH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHROPLASTY KNEE TIBIAL PLATEAU | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHROSCOPY KNEE INFECTION LAVAGE & DRAINAGE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHROSCOPY KNEE SYNOVECTOMY 2/>COMPARTMENTS | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| ARTHROSCOPY KNEE W/MENISCUS RPR MEDIAL/LATERAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHROSCOPY SHOULDER DISTAL CLAVICULECTOMY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHROSCOPY SHOULDER ROTATOR CUFF REPAIR | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| ARTHROSCOPY SHOULDER SURGICAL CAPSULORRHAPHY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHROTOMY ELBOW W/SYNOVECTOMY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHRP ACETBLR/PROX FEM PROSTC AGRFT/ALGRFT | 237 (<0.1%) | 123 (<0.1%) | 114 (<0.1%) | |
| ARTHRP ELBOW W/DISTAL HUM&PROX UR PROSTC RPLCM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRP INTERPOS INTERCARPAL/METACARPAL JOINTS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRP KNE CONDYLE&PLATU MEDIAL&LAT COMPARTMENTS | 456 (<0.1%) | 300 (<0.1%) | 156 (<0.1%) | |
| ARTHRP KNEE CONDYLE&PLATEAU MEDIAL/LAT CMPRT | 11 (<0.1%) | 8 (<0.1%) | 3 (<0.1%) | |
| ARTHRP TEMPOROMANDIBULAR JOINT W/WO AUTOGRAFT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRS AIDED ANT CRUCIATE LIGM RPR/AGMNTJ/RCNSTJ | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| ARTHRS KNE SURG W/MENISCECTOMY MED/LAT W/SHVG | 5 (<0.1%) | 3 (<0.1%) | 2 (<0.1%) | |
| ARTHRS KNEE DEBRIDEMENT/SHAVING ARTCLR CRTLG | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHRS KNEE W/MENISCECTOMY MED&LAT W/SHAVING | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| ARTHRT ELBOW CAPSULAR EXCISION CAPSULAR RLS SPX | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ARTHRT ELBOW W/EXPLORATION DRAINAGE/REMOVAL FB | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ARTHRT KNE W/EXPL DRG/RMVL FB | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| ARTHRT W/EXC SEMILUNAR CRTLG KNEE MEDIAL/LAT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| AS-AORT GRF W/CARD BYP & AORTIC ROOT RPLCMT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| AXILLARY LYMPHADENECTOMY COMPLETE | 357 (<0.1%) | 215 (<0.1%) | 142 (<0.1%) | |
| AXILLARY LYMPHADENECTOMY SUPERFICIAL | 43 (<0.1%) | 33 (<0.1%) | 10 (<0.1%) | |
| BILIARY NDSC INTRAOPERATIVE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BIOPSY PANCREAS OPEN | 86 (<0.1%) | 46 (<0.1%) | 40 (<0.1%) | |
| BIOPSY STOMACH LAPAROTOMY | 15 (<0.1%) | 9 (<0.1%) | 6 (<0.1%) | |
| BONE GRAFT ANY DONOR AREA MINOR/SMALL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BONE GRAFT MICROVASCULAR ANASTOMOSIS FIBULA | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| BRACH ART EXPOS DPLMNT AORTIC/ILIAC PROSTH UNI | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BREAST RECONSTRUCTION FREE FLAP | 146 (<0.1%) | 146 (<0.1%) | 0 (0%) | |
| BREAST RECONSTRUCTION OTHER TECHNIQUE | 30 (<0.1%) | 30 (<0.1%) | 0 (0%) | |
| BREAST RECONSTRUCTION TRAM 1 PEDCL MVASC ANAST | 6 (<0.1%) | 6 (<0.1%) | 0 (0%) | |
| BREAST RECONSTRUCTION TRAM FLAP 1 PEDICLE | 12 (<0.1%) | 12 (<0.1%) | 0 (0%) | |
| BREAST RECONSTRUCTION TRAM FLAP DOUBLE PEDICLE | 27 (<0.1%) | 27 (<0.1%) | 0 (0%) | |
| BRST RCNSTJ IMMT/DLYD W/TISS EXPANDER SBSQ XPNSJ | 1,062 (0.2%) | 1,061 (0.3%) | 1 (<0.1%) | |
| BRST RCNSTJ W/LATSMS D/SI FLAP WO PRSTHC IMPL | 63 (<0.1%) | 63 (<0.1%) | 0 (0%) | |
| BSO W/OMENTECTOMY TAH DEBULKING W/LMPHADECTOMY | 17 (<0.1%) | 17 (<0.1%) | 0 (0%) | |
| BSO W/OMENTECTOMY TAH&RAD DEBULKING DISSECTION | 33 (<0.1%) | 33 (<0.1%) | 0 (0%) | |
| BSO W/TOT OMENTECTOMY & HYSTERECTOMY MALIGNANC | 14 (<0.1%) | 14 (<0.1%) | 0 (0%) | |
| BYP FEM-ANT TIBL PST TIBL PRONEAL ART/OTH DSTL | 91 (<0.1%) | 22 (<0.1%) | 69 (<0.1%) | |
| BYP OTH/THN VEIN AORTOBI-ILIAC | 7 (<0.1%) | 5 (<0.1%) | 2 (<0.1%) | |
| BYP OTH/THN VEIN AORTOBIFEMORAL | 105 (<0.1%) | 51 (<0.1%) | 54 (<0.1%) | |
| BYP OTH/THN VEIN AORTOCELIAC AORTOMSN AORTORNL | 7 (<0.1%) | 3 (<0.1%) | 4 (<0.1%) | |
| BYP OTH/THN VEIN AORTOFEMORAL | 5 (<0.1%) | 2 (<0.1%) | 3 (<0.1%) | |
| BYP OTH/THN VEIN AORTOILIAC | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| BYP OTH/THN VEIN AXILLARY-AXILLARY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYP OTH/THN VEIN AXILLARY-FEMORAL | 10 (<0.1%) | 2 (<0.1%) | 8 (<0.1%) | |
| BYP OTH/THN VEIN AXILLARY-FEMORAL-FEMORAL | 15 (<0.1%) | 8 (<0.1%) | 7 (<0.1%) | |
| BYP OTH/THN VEIN CAROTID-SUBCLAVIAN | 15 (<0.1%) | 8 (<0.1%) | 7 (<0.1%) | |
| BYP OTH/THN VEIN COMMON-IPSILATERAL CAROTID | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| BYP OTH/THN VEIN FEM-ANT TIBL PST TIBL/PRONEAL | 48 (<0.1%) | 14 (<0.1%) | 34 (<0.1%) | |
| BYP OTH/THN VEIN FEMORAL-FEMORAL | 77 (<0.1%) | 32 (<0.1%) | 45 (<0.1%) | |
| BYP OTH/THN VEIN FEMORAL-POPLITEAL | 175 (<0.1%) | 52 (<0.1%) | 123 (<0.1%) | |
| BYP OTH/THN VEIN ILIOFEMORAL | 11 (<0.1%) | 1 (<0.1%) | 10 (<0.1%) | |
| BYP OTH/THN VEIN POPLITEAL-TIBIAL/-PERONEAL ART | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| BYP TIBL-TIBL/PRONEAL-TIBL/TIBL/PRONEAL TRK-TIBL | 5 (<0.1%) | 2 (<0.1%) | 3 (<0.1%) | |
| BYP W/VEIN POP-TIBL-PRONEAL ART/OTH DSTL VSL | 37 (<0.1%) | 8 (<0.1%) | 29 (<0.1%) | |
| BYPASS COMPOSITE GRAFT PROSTHETIC & VEIN | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BYPASS GRAFT W/OTHER THAN VEIN ILIO-CELIAC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYPASS GRAFT W/OTHER THAN VEIN ILIO-MESENTERIC | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN AORTOBI-ILIAC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYPASS W/VEIN AORTOBIFEMORAL | 7 (<0.1%) | 3 (<0.1%) | 4 (<0.1%) | |
| BYPASS W/VEIN AORTOCELIAC/AORTOMESENTERIC | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| BYPASS W/VEIN AORTOFEMORAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN AORTOILIAC | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN AXILLARY-BRACHIAL | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN AXILLARY-FEMORAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN AXILLARY-FEMORAL-FEMORAL | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| BYPASS W/VEIN BRACHIAL-BRACHIAL | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| BYPASS W/VEIN BRACHIAL-ULNAR/-RADIAL | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| BYPASS W/VEIN CAROTID-BRACHIAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYPASS W/VEIN CAROTID-SUBCLV/SUBCLAVIAN CAROTID | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYPASS W/VEIN COMMON-IPSILATERAL CAROTID | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN FEMORAL-FEMORAL | 14 (<0.1%) | 7 (<0.1%) | 7 (<0.1%) | |
| BYPASS W/VEIN FEMORAL-POPLITEAL | 146 (<0.1%) | 49 (<0.1%) | 97 (<0.1%) | |
| BYPASS W/VEIN HEPATORENAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYPASS W/VEIN ILIOFEMORAL | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| BYPASS W/VEIN SPLENORENAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| BYPASS W/VEIN SUBCLAVIAN-AXILLARY | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CABG W/ARTERIAL GRAFT SINGLE ARTERIAL GRAFT | 26 (<0.1%) | 8 (<0.1%) | 18 (<0.1%) | |
| CAPSULAR CONTRACTURE RELEASE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CARINAL RECONSTRUCTION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CERVICAL LYMPHADEC MODIFIED RADICAL NECK DSJ | 526 (<0.1%) | 297 (<0.1%) | 229 (0.1%) | |
| CERVICAL LYMPHADENECTOMY | 44 (<0.1%) | 20 (<0.1%) | 24 (<0.1%) | |
| CHOLECSTC EXPL DUX SPHNCTROTOMY/SPHNCTROP | 13 (<0.1%) | 4 (<0.1%) | 9 (<0.1%) | |
| CHOLECSTONTRSTM ROUX-EN-Y W/GASTRONTRSTM | 38 (<0.1%) | 14 (<0.1%) | 24 (<0.1%) | |
| CHOLECSTOT/CHOLECSTOST W/EXPL DRG/RMVL ST1 SPX | 47 (<0.1%) | 21 (<0.1%) | 26 (<0.1%) | |
| CHOLECYSTECTOMY | 3,200 (0.6%) | 1,556 (0.5%) | 1,644 (0.8%) | |
| CHOLECYSTECTOMY EXPL DUCT CHOLEDOCHOENTEROSTOMY | 53 (<0.1%) | 27 (<0.1%) | 26 (<0.1%) | |
| CHOLECYSTECTOMY W/CHOLANGIOGRAPHY | 633 (0.1%) | 328 (0.1%) | 305 (0.1%) | |
| CHOLECYSTECTOMY W/EXPLORATION COMMON DUCT | 243 (<0.1%) | 126 (<0.1%) | 117 (<0.1%) | |
| CHOLECYSTOENTEROSTOMY DIRECT | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| CHOLECYSTOENTEROSTOMY ROUX-EN-Y | 16 (<0.1%) | 6 (<0.1%) | 10 (<0.1%) | |
| CHOLECYSTOSTOMY PRQ W/IMAGING & CATHETER PLMT | 8 (<0.1%) | 6 (<0.1%) | 2 (<0.1%) | |
| CHOLEDOCHOT/OST W/O SPHNCTROTOMY/SPHNCTROP | 51 (<0.1%) | 32 (<0.1%) | 19 (<0.1%) | |
| CHOLEDOCHOT/OST W/SPHNCTROTOMY/SPHNCTROP | 13 (<0.1%) | 9 (<0.1%) | 4 (<0.1%) | |
| CLOSE MEDIAN STERNOTOMY SEP W/WO DEBRIDEMENT SPX | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CLOSURE ENTEROSTOMY LG/SMALL INTESTINE | 6,353 (1.2%) | 2,847 (0.9%) | 3,506 (1.6%) | |
| CLOSURE GASTROCOLIC FISTULA | 29 (<0.1%) | 20 (<0.1%) | 9 (<0.1%) | |
| CLOSURE GASTROSTOMY SURG | 82 (<0.1%) | 40 (<0.1%) | 42 (<0.1%) | |
| CLOSURE INTESTINAL CUTANEOUS FISTULA | 580 (0.1%) | 302 (<0.1%) | 278 (0.1%) | |
| CLOSURE NEPHROCUTANEOUS/PYELOCUTANEOUS FISTULA | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CLOSURE RECTOURETHRAL FISTULA | 21 (<0.1%) | 0 (0%) | 21 (<0.1%) | |
| CLOSURE RECTOURETHRAL FISTULA W/COLOSTOMY | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| CLOSURE RECTOVESICAL FISTULA | 16 (<0.1%) | 5 (<0.1%) | 11 (<0.1%) | |
| CLOSURE URETEROCUTANEOUS FISTULA W/VISC RPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CLSR ENTEROENTERIC/ENTEROCOLIC FSTL | 172 (<0.1%) | 91 (<0.1%) | 81 (<0.1%) | |
| CLSR ENTEROVES FSTL W/INTESTINE&/BLADDER RESCJ | 385 (<0.1%) | 159 (<0.1%) | 226 (0.1%) | |
| CLSR ENTEROVES FSTL W/O INTSTINAL/BLADDER RESCJ | 29 (<0.1%) | 12 (<0.1%) | 17 (<0.1%) | |
| CLSR ESOPHAGOSTOMY/FSTL TTHRC/TABDL APPR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CLSR NTRSTM LG/SM RESCJ & ANAST OTH/THN CLRCT | 9,765 (1.8%) | 4,371 (1.3%) | 5,394 (2.5%) | |
| CLSR NTRSTM LG/SM RESCJ & COLORECTAL ANASTOMOSIS | 6,188 (1.1%) | 2,958 (0.9%) | 3,230 (1.5%) | |
| CLSR RECTOVAG FSTL ABDL APPR W/CONCOMITANT CLST | 9 (<0.1%) | 9 (<0.1%) | 0 (0%) | |
| CLSR RECTOVAG FSTL TPRNL PRNL BDY RCNSTJ | 40 (<0.1%) | 39 (<0.1%) | 1 (<0.1%) | |
| CLSR RECTOVAGINAL FISTULA ABDOMINAL APPROACH | 31 (<0.1%) | 30 (<0.1%) | 1 (<0.1%) | |
| CLSR RECTOVAGINAL FISTULA VAGINAL/TRANSANAL APPR | 76 (<0.1%) | 76 (<0.1%) | 0 (0%) | |
| CLSR RECTOVESICAL FISTULA W/COLOSTOMY | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| CLSR V-SEPTAL DFCT W/RMVL P-ART BAND W/WO GUSSET | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CLTR SKIN AGRFT F/S/N/H/F/G/M/D GT ADDL 1-75CM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CLTR SKIN AGRFT T/A/L ADDL 1 CM-75 CM | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| CLTR SKIN AUTOGRAFT T/A/L 1ST 25 CM/< | 9 (<0.1%) | 5 (<0.1%) | 4 (<0.1%) | |
| CMBND ANTEROPOST COLPORRHAPHY W/ENTEROCELE RPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CMBND ANTERPOST COLPORRAPHY W/CYSTO W/NTRCL RPR | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| COCCYGECTOMY PRIMARY | 13 (<0.1%) | 10 (<0.1%) | 3 (<0.1%) | |
| COLCT TOT ABDL W/O PRCTECT W/CONTINENT ILEOST | 62 (<0.1%) | 27 (<0.1%) | 35 (<0.1%) | |
| COLCT TOT ABDL W/O PRCTECT W/ILEOST/ILEOPXTS | 1,659 (0.3%) | 843 (0.3%) | 816 (0.4%) | |
| COLCT TTL ABD W/PRCTECT ILEOANAL ANAST & RSVR | 601 (0.1%) | 246 (<0.1%) | 355 (0.2%) | |
| COLECTOMY PARTIAL W/ANASTOMOSIS | 15,723 (2.9%) | 8,165 (2.5%) | 7,558 (3.5%) | |
| COLECTOMY PRTL ABDOMINAL & TRANSANAL APPROACH | 262 (<0.1%) | 127 (<0.1%) | 135 (<0.1%) | |
| COLECTOMY PRTL W/COLOPROCTOSTOMY | 11,843 (2.2%) | 6,088 (1.9%) | 5,755 (2.7%) | |
| COLECTOMY PRTL W/COLOPROCTOSTOMY & COLOSTOMY | 1,767 (0.3%) | 822 (0.3%) | 945 (0.4%) | |
| COLECTOMY PRTL W/COLOST/ILEOST & MUCOFISTULA | 869 (0.2%) | 447 (0.1%) | 422 (0.2%) | |
| COLECTOMY PRTL W/END COLOSTOMY & CLSR DSTL SGMT | 2,168 (0.4%) | 1,103 (0.3%) | 1,065 (0.5%) | |
| COLECTOMY PRTL W/RMVL TERMINAL ILEUM & ILEOCOLOS | 9,628 (1.8%) | 5,016 (1.5%) | 4,612 (2.1%) | |
| COLECTOMY PRTL W/SKIN LEVEL CECOST/COLOSTOMY | 840 (0.2%) | 464 (0.1%) | 376 (0.2%) | |
| COLECTOMY TOT ABD W/PROCTECTOMY ILEOANAL ANAST | 326 (<0.1%) | 155 (<0.1%) | 171 (<0.1%) | |
| COLECTOMY TOT ABDL W/PROCTECTOMY W/CONTNT ILEOST | 48 (<0.1%) | 25 (<0.1%) | 23 (<0.1%) | |
| COLECTOMY TOT ABDL W/PROCTECTOMY W/ILEOSTOMY | 935 (0.2%) | 442 (0.1%) | 493 (0.2%) | |
| COLOSTOMY/SKIN LEVEL CECOSTOMY | 756 (0.1%) | 405 (0.1%) | 351 (0.2%) | |
| COLOSTOMY/SKN LVL CECOSTOMY W/MULT BXS SPX | 15 (<0.1%) | 6 (<0.1%) | 9 (<0.1%) | |
| COLOTOMY EXPLORATION/BIOPSY/FOREIGN BODY REMOVAL | 42 (<0.1%) | 23 (<0.1%) | 19 (<0.1%) | |
| COLPOCLEISIS LE FORT TYPE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| COLPOPERINEORRHAPHY SUTURE INJ VAGINA&/PERINEU | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| COLPOPEXY ABDOMINAL APPROACH | 7 (<0.1%) | 7 (<0.1%) | 0 (0%) | |
| COLPOPEXY VAGINAL EXTRAPERITONEAL APPROACH | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| COLPOPEXY VAGINAL INTRAPERITONEAL APPROACH | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| COLPORRHAPHY SUTURE INJURY VAGINA | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| COLPOTOMY W/DRAINAGE PELVIC ABSCESS | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| COMBINED ANTEROPOSTERIOR COLPORRHAPHY | 6 (<0.1%) | 6 (<0.1%) | 0 (0%) | |
| CONTINENT DVRJ W/INT ANAST ANY SGM SM&/LG INTSTN | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| CONTINENT ILEOSTOMY KOCK PROCEDURE SPX | 18 (<0.1%) | 9 (<0.1%) | 9 (<0.1%) | |
| CONV PREV HIP TOT HIP ARTHRP W/WO AGRFT/ALGRFT | 5 (<0.1%) | 2 (<0.1%) | 3 (<0.1%) | |
| CORONARY ARTERY BYP W/VEIN & ARTERY GRAFT 2 VEIN | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| CORONARY ARTERY BYP W/VEIN & ARTERY GRAFT 3 VEIN | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CORONARY ARTERY BYP W/VEIN & ARTERY GRAFT 5 VEIN | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CORONARY ARTERY BYPASS 1 CORONARY VENOUS GRAFT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CORONARY ARTERY BYPASS 2 CORONARY VENOUS GRAFTS | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CORONARY ENDARTERCOMY OPEN ANY METHOD | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| CORONOIDECTOMY SEPARATE PROCEDURE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CORRJ MALROTATION BANDS&/RDCTJ VOLVULUS | 63 (<0.1%) | 41 (<0.1%) | 22 (<0.1%) | |
| CRANFCL ANT CRANIAL FOSSA UNI/BIFRNTL ELEV LOBE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CRANIEC TREPHINE BONE FLP BRAIN TUMOR SUPRTENTOR | 19 (<0.1%) | 8 (<0.1%) | 11 (<0.1%) | |
| CRANIECTOMY HMTMA INFRATENTORIAL EXTRA/SUBDURAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRANIECTOMY HMTMA SUPRATENTORIAL EXTRA/SUBDURAL | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| CRANIECTOMY/CRANIOTMY DRG ABSCESS SUPRATENTORIAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRANIECTOMY/CRANIOTOMY EXPL SUPRATENTORIAL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CRANIOFACIAL ANT CRANIAL FOSSA W/O ORBITAL EXNTJ | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CRANIOFACIAL ANT CRANIAL FOSSA W/ORBITAL EXNTJ | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRANIOT HYPOPHYSEC/EXC PITUITARY TUMOR ICRL APPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRANIOT LOBEC TEMPORAL LOBE W/ELECTROCORTCOGRPHY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CRANIOT TEMPORAL LOBE W/O ELECTROCORTICOGRAPHY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CRICOPHARYNGEAL MYOTOMY | 8 (<0.1%) | 4 (<0.1%) | 4 (<0.1%) | |
| CRNEC EXC BRAIN TUMOR INFRATENTORIAL/POST FOSSA | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| CRNEC EXC TUM INFRATENTOR/POST FOSSA MENINGIOMA | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRNEC SUBOCCIPITAL CRV LAM DCMPRN MEDULLA & CORD | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRNEC TRANSTEMPOR EXC CEREBELLOPONTINE ANGLE TUM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRNEC TREPHINE BONE FLAP FENEST CYST SUPRATENTOR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CRNEC TREPHINE BONE FLAP MENINGIOMA SUPRATENTOR | 15 (<0.1%) | 11 (<0.1%) | 4 (<0.1%) | |
| CRNEC TUM INFRATTL/POSTFOSSA CRBLOPNT ANGLE TUM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CROSS-OVER VEIN GRAFT VENOUS SYSTEM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CRTJ DSTL ARVEN FSTL LXTR BYP SURG NON-HEMO | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| CRTJ PERICARDIAL WINDOW/PRTL RESECJ W/DRG/BX | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| CSTC COMPL W/CONDUIT/SIGMOID BLDR PEL LMPHADEC | 37 (<0.1%) | 13 (<0.1%) | 24 (<0.1%) | |
| CSTC COMPL W/CONTINENT DVRJ OPN NEOBLDR | 9 (<0.1%) | 2 (<0.1%) | 7 (<0.1%) | |
| CSTC COMPL W/URTROILEAL CONDUIT/BLDR W/INT ANAST | 19 (<0.1%) | 9 (<0.1%) | 10 (<0.1%) | |
| CSTC PRTL W/RIMPLTJ URTR IN BLDR URTRONEOCSTOST | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| CSTOPLASTY/CSTOURTP PLSTC ANY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| CURTG/CAUT ANAL FISSURE W/DILAT SPHNCTR SPX 1ST | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| CURTG/CAUT ANAL FISSURE W/DILAT SPHNCTR SPX SBSQ | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CUTANANEOUS APPENDICO-VESICOSTOMY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CYSTECTOMY COMPLETE SEPARATE PROCEDURE | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| CYSTECTOMY PARTIAL COMPLICATED | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| CYSTECTOMY PARTIAL SIMPLE | 19 (<0.1%) | 10 (<0.1%) | 9 (<0.1%) | |
| CYSTECTOMY W/BI PELVIC LYMPHADENECTOMY | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| CYSTO W/REMOVAL OF TUMORS SMALL | 9 (<0.1%) | 2 (<0.1%) | 7 (<0.1%) | |
| CYSTO/PYELOSCOPY BX&/FULGURATION PELIVC LESION | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| CYSTOLITHOTOMY CYSTOTOMY W/RMVL CALCULUS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CYSTORRHAPHY SUTR BLDR WND INJ/RPT SIMPLE | 7 (<0.1%) | 6 (<0.1%) | 1 (<0.1%) | |
| CYSTOSTOMY CYSTOTOMY W/DRAINAGE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CYSTOTOMY EXCISE BLADDER DIVERTICULUM 1/MULTIPLE | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| CYSTOTOMY EXCISION BLADDER TUMOR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| CYSTOURETHROSCOPY W/DEST &/RMVL MED BLADDER TUM | 12 (<0.1%) | 4 (<0.1%) | 8 (<0.1%) | |
| CYSTOURETHROSCOPY W/DEST &/RMVL TUMOR LARGE | 10 (<0.1%) | 2 (<0.1%) | 8 (<0.1%) | |
| DBRDMT EXTENSV ECZEMA/INFECT SKN UP 10% BDY SURF | 73 (<0.1%) | 34 (<0.1%) | 39 (<0.1%) | |
| DBRDMT FX&/DISLC SUBQ T/M/F BONE | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| DBRDMT SKN SUBQ T/M/F NECRO INFCTJ ABDL WALL | 147 (<0.1%) | 86 (<0.1%) | 61 (<0.1%) | |
| DBRDMT SKN SUBQ T/M/F NECRO INFCTJ GENT&PR | 42 (<0.1%) | 17 (<0.1%) | 25 (<0.1%) | |
| DBRDMT SKN SUBQ T/M/F NECRO INFCTJ GENT/ABDL | 12 (<0.1%) | 9 (<0.1%) | 3 (<0.1%) | |
| DBRDMT W/RMVL FM FX&/DISLC SKIN&SUBQ TISSUS | 9 (<0.1%) | 7 (<0.1%) | 2 (<0.1%) | |
| DBRDMT W/RMVL FM FX&/DISLC SKN SUBQ T/M/F MUSC | 8 (<0.1%) | 1 (<0.1%) | 7 (<0.1%) | |
| DCMPRN FASCT LEG ANT&/LAT COMPARTMENTS ONLY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DCMPRN FASCT LEG ANT&/LAT W/DBRDMT MUSC&/NERVE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| DCMPRN FASCT LEG ANT&/LAT&PST CMPRT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DCMPRN FASCT LEG ANT&/LAT&PST W/DBRDMT MUS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DCMPRN FASCT LEG POST COMPARTMENT ONLY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DCMPRN FASCT LEG PST W/DBRDMT MUSC&/NRV | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DCMPRN FASCT THIGH&/KNEE MLT DBRDMT NV MUSC&NRVE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DEBRIDEMENT BONE MUSCLE &/FASCIA 20 SQ CM/< | 145 (<0.1%) | 53 (<0.1%) | 92 (<0.1%) | |
| DEBRIDEMENT MUSCLE & FASCIA 20 SQ CM/< | 389 (<0.1%) | 173 (<0.1%) | 216 (<0.1%) | |
| DEBRIDEMENT SUBCUTANEOUS TISSUE 20 SQ CM/< | 562 (0.1%) | 306 (<0.1%) | 256 (0.1%) | |
| DECOMPRESSION FASCIOTOMY PELVIC COMPARTMENT UNI | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DECOMPRESSION UNSPECIFIED NERVE | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| DECORTICATION & PARIETAL PLEURECTOMY | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| DECORTICATION PULMONARY PARTIAL SEPARATE PROC | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| DECORTICATION PULMONARY TOTAL SEPARATE PROCEDURE | 15 (<0.1%) | 4 (<0.1%) | 11 (<0.1%) | |
| DELAY FLAP/SECTIONING FLAP SCALP ARMS/LEGS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DESTRUCTION LESION DENTOALVEOLAR STRUCTURES | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DESTRUCTION RECTAL TUMOR TRANSANAL APPROACH | 22 (<0.1%) | 9 (<0.1%) | 13 (<0.1%) | |
| DIR RPR ANEURYSM & GRAFT COMMON FEMORAL ARTERY | 18 (<0.1%) | 7 (<0.1%) | 11 (<0.1%) | |
| DIR RPR ANEURYSM & GRAFT ILIAC ARTERY | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| DIR RPR ANEURYSM & GRAFT POPLITEAL ARTERY | 17 (<0.1%) | 1 (<0.1%) | 16 (<0.1%) | |
| DIR RPR ANEURYSM ABDOM AORTA W/ILIAC VESSELS | 35 (<0.1%) | 4 (<0.1%) | 31 (<0.1%) | |
| DIR RPR ANEURYSM ABDOM AORTA W/VISCERAL VESSELS | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| DIR RPR ANEURYSM ABDOMINAL AORTA | 37 (<0.1%) | 7 (<0.1%) | 30 (<0.1%) | |
| DIR RPR ANEURYSM AXIL-BRACHIAL ARM INCISION | 9 (<0.1%) | 1 (<0.1%) | 8 (<0.1%) | |
| DIR RPR ANEURYSM CAROTID-SUBCLAVIAN ARTERY | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| DIR RPR ANEURYSM HEPATIC/CELIAC/RENAL/MESENTERIC | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| DIR RPR ANEURYSM SPLENIC ARTERY | 8 (<0.1%) | 4 (<0.1%) | 4 (<0.1%) | |
| DIR RPR RUPTD ANEURYSM & GRAFT ILIAC ARTERY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DIR RPR RUPTD ANEURYSM & GRF COMMON FEMORAL ART | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| DIR RPR RUPTD ANEURYSM ABDOM AORTA W/ILIAC VSLS | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| DIR RPR RUPTD ANEURYSM ABDOMINAL AORTA | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| DIR RPR RUPTD ANEURYSM AXIL-BRACHIAL ARM INCIS | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| DIR RPR RUPTD ANEURYSM RADIAL/ULNAR ARTERY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DIR RPR RUPTD ANEURYSM SPLENIC ARTERY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DISARTICULATION HIP | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| DISARTICULATION KNEE | 14 (<0.1%) | 3 (<0.1%) | 11 (<0.1%) | |
| DISARTICULATION SHOULDER | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DISCECTOMY ANT DCMPRN CORD CERVICAL 1 NTRSPC | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| DISSECTION DEEP JUGULAR NODE | 10 (<0.1%) | 5 (<0.1%) | 5 (<0.1%) | |
| DIVERTICULECTOMY HYPOPHARYNX/ESOPH CRV APPR | 54 (<0.1%) | 18 (<0.1%) | 36 (<0.1%) | |
| DIVERTICULECTOMY HYPOPHARYNX/ESOPH THRC APPR | 11 (<0.1%) | 6 (<0.1%) | 5 (<0.1%) | |
| DIVISION SCALENUS ANTICUS RESECTION CERVICAL RIB | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| DIVISION SCALENUS ANTICUS W/O RESCJ CERVICAL RIB | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DIVISION STRICTURE RECTUM | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| DLYD INSJ BRST PROSTH FLWG MASTOPEXY MAST/RCNSTJ | 12 (<0.1%) | 12 (<0.1%) | 0 (0%) | |
| DLYD PLACEMENT XTN PROSTH FOR EVASC RPR 1ST VSL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DNRVTJ HIP JT INTRAPEL/XTRPEL INTRA-ARTCLR BRNCH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DRAINAGE DEEP PERIURETHRAL ABSCESS | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| DRAINAGE OF RETROPERITONEAL ABSCESS OPEN | 34 (<0.1%) | 22 (<0.1%) | 12 (<0.1%) | |
| DRAINAGE PERITON ABSCESS/LOCAL PERITONITIS OPEN | 136 (<0.1%) | 79 (<0.1%) | 57 (<0.1%) | |
| DRAINAGE SCROTAL WALL ABSCESS | 8 (<0.1%) | 0 (0%) | 8 (<0.1%) | |
| DRAINAGE SUBDIAPHRAGMATIC/SUBPHREN ABSCESS OPEN | 16 (<0.1%) | 7 (<0.1%) | 9 (<0.1%) | |
| DRG ABSC CST HMTMA VESTIBULE MOUTH COMP | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| DRG ABSC CST HMTMA VESTIBULE MOUTH SMPL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| DRG XTRAPERITONEAL LYMPHOCELE PERITON CAVITY OPN | 7 (<0.1%) | 3 (<0.1%) | 4 (<0.1%) | |
| DSTL REVSC&INTERVAL LIG UXTR HEMO ACCESS | 9 (<0.1%) | 5 (<0.1%) | 4 (<0.1%) | |
| DUODENOTOMY EXPLORATION/BX/FOREIGN BODY REMOVAL | 44 (<0.1%) | 28 (<0.1%) | 16 (<0.1%) | |
| DUOL EXCLUSION W/GASTROJEJUNOSTOMY PNCRTC INJ | 8 (<0.1%) | 6 (<0.1%) | 2 (<0.1%) | |
| EGST W/WO VAGOTOMY&PYLOROPLASTY TABDL/TTHRC AP | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| EMBLC/THRMBC AX BRACH INNOMINATE SUBCLA ART | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| EMBLC/THRMBC CATH CRTD SUBCLA/INNOMINATE ART | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| EMBLC/THRMBC FEMORAL POPLITEAL AORTO-ILIAC ART | 12 (<0.1%) | 6 (<0.1%) | 6 (<0.1%) | |
| EMBLC/THRMBC POPLITEAL-TIBIO-PRONEAL ART LEG INC | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| EMBLC/THRMBC RNL CELIAC MESENTRY AORTO-ILIAC ART | 8 (<0.1%) | 3 (<0.1%) | 5 (<0.1%) | |
| ENDOVEN ABLTJ INCMPTNT VEIN XTR LASER 1ST VEIN | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ENDOVEN ABLTJ INCMPTNT VEIN XTR RF 1ST VEIN | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| ENTERECTOMY RESCJ SMALL INTESTINE EA RESCJ & ANA | 38 (<0.1%) | 17 (<0.1%) | 21 (<0.1%) | |
| ENTERECTOMY RESCJ SMALL INTESTINE W/ENTEROSTOMY | 187 (<0.1%) | 97 (<0.1%) | 90 (<0.1%) | |
| ENTEROENTEROST ANAST INT W/WO CUTAN NTRSTM SPX | 430 (<0.1%) | 231 (<0.1%) | 199 (<0.1%) | |
| ENTEROLSS FRING INTSTINAL ADHESION SPX | 1,286 (0.2%) | 762 (0.2%) | 524 (0.2%) | |
| ENTERORRHAPHY 1PERFORATION | 137 (<0.1%) | 83 (<0.1%) | 54 (<0.1%) | |
| ENTERORRHAPHY MULTIPLE PERFORATIONS | 54 (<0.1%) | 36 (<0.1%) | 18 (<0.1%) | |
| ENTEROTOMY SM INT OTH/THN DUO DCMPRN | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| ENTEROTOMY SM INT OTH/THN DUO EXPL BX/FB RMVL | 65 (<0.1%) | 45 (<0.1%) | 20 (<0.1%) | |
| ENTRC RESCJ ATRESIA RESCJ & ANAST SGM W/TAPRING | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| ENTRC RESCJ ATRESIA RESCJ & ANAST W/O TAPRING | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| ENTRC RESCJ SMALL INTESTINE 1 RESCJ & ANAST | 4,616 (0.9%) | 2,367 (0.7%) | 2,249 (1.0%) | |
| ESOPG/GSTR FUNDOPLASTY W/FUNDIC PATCH | 41 (<0.1%) | 28 (<0.1%) | 13 (<0.1%) | |
| ESOPG/GSTR FUNDOPLASTY W/LAPAROTOMY | 90 (<0.1%) | 67 (<0.1%) | 23 (<0.1%) | |
| ESOPG/GSTR FUNDOPLASTY W/THORACOTOMY | 5 (<0.1%) | 4 (<0.1%) | 1 (<0.1%) | |
| ESOPHAGECTOMY DISTAL 2/3 W/LAPAROSCOPIC MOBLJ | 157 (<0.1%) | 24 (<0.1%) | 133 (<0.1%) | |
| ESOPHAGECTOMY TOTAL NEAR TOTAL W/LAPS MOBLJ | 46 (<0.1%) | 12 (<0.1%) | 34 (<0.1%) | |
| ESOPHAGECTOMY TOTAL NEAR TOTAL W/THRSC MOBLJ | 81 (<0.1%) | 20 (<0.1%) | 61 (<0.1%) | |
| ESOPHAGOJEJUNOSTOMY W/O TOT GSTRCT ABDL APPR | 22 (<0.1%) | 16 (<0.1%) | 6 (<0.1%) | |
| ESOPHAGOMYOTOMY HELLER TYPE ABDOMINAL APPROACH | 39 (<0.1%) | 16 (<0.1%) | 23 (<0.1%) | |
| ESOPHAGOMYOTOMY HELLER TYPE THORACIC APPROACH | 5 (<0.1%) | 2 (<0.1%) | 3 (<0.1%) | |
| ESOPHAGOTOMY CERVICAL APPR W/RMVL FB | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| ESPHGP CGEN DFCT THRC APPR W/O RPR FSTL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ESPHGP CGEN DFCT THRC APPR W/RPR FSTL | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| ESPHGP CRV APPR W/O RPR TRACHEOESOPHGL FSTL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ESPHGP CRV APPR W/RPR TRACHEOESOPHGL FSTL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| ESPHGP THRC APPR W/O RPR TRACHEOESOPHGL FSTL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| EVASC RPR AAA AORTO-UNIILIAC/AORTO-UNIFEM PROSTH | 10 (<0.1%) | 3 (<0.1%) | 7 (<0.1%) | |
| EVASC RPR AAA W/AORTO-AORTIC TUBE PROSTH | 24 (<0.1%) | 5 (<0.1%) | 19 (<0.1%) | |
| EVASC RPR AAA W/MDLR BFRC PROSTH 1 LIMB | 138 (<0.1%) | 20 (<0.1%) | 118 (<0.1%) | |
| EVASC RPR AAA W/MDLR BFRC PROSTH 2 LIMBS | 113 (<0.1%) | 19 (<0.1%) | 94 (<0.1%) | |
| EVASC RPR AAA W/UNIBDY BFRC PROSTH | 43 (<0.1%) | 4 (<0.1%) | 39 (<0.1%) | |
| EVASC RPR DPLMNT AORTO-AORTIC NDGFT | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| EVASC RPR DPLMNT AORTO-BI-ILIAC NDGFT | 54 (<0.1%) | 10 (<0.1%) | 44 (<0.1%) | |
| EVASC RPR DPLMNT AORTO-BI-ILIAC NDGFT RPT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EVASC RPR DPLMNT AORTO-UN-ILIAC NDGFT | 9 (<0.1%) | 0 (0%) | 9 (<0.1%) | |
| EXC 1/> SM/LG LESIONS INTESTNE MULT ENTEROTOMIE | 26 (<0.1%) | 18 (<0.1%) | 8 (<0.1%) | |
| EXC 1/> SMALL/LARGE LESIONS INTESTINE ENTEROTOM | 290 (<0.1%) | 134 (<0.1%) | 156 (<0.1%) | |
| EXC BILE DUX TUM W/WO PRIM RPR INTRAHEPATC | 11 (<0.1%) | 6 (<0.1%) | 5 (<0.1%) | |
| EXC BILE DUX TUM W/WO PRIM RPR XTRHEPATC | 91 (<0.1%) | 44 (<0.1%) | 47 (<0.1%) | |
| EXC COCCYGEAL PR ULC W/COCCYGECTOMY W/PRIM SUTR | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| EXC ILEOANAL RSVR W/ILEOSTOMY | 185 (<0.1%) | 96 (<0.1%) | 89 (<0.1%) | |
| EXC LOCAL MALIGNANT TUMOR STOMACH | 475 (<0.1%) | 236 (<0.1%) | 239 (0.1%) | |
| EXC LOCAL ULCER/BENIGN TUMOR STOMACH | 334 (<0.1%) | 182 (<0.1%) | 152 (<0.1%) | |
| EXC MECKEL'S DIVERTICULUM/OMPHALOMESENTERIC DUCT | 37 (<0.1%) | 14 (<0.1%) | 23 (<0.1%) | |
| EXC PRTD TUM/PRTD GLND TOT DSJ&PRSRV FACIAL NR | 38 (<0.1%) | 16 (<0.1%) | 22 (<0.1%) | |
| EXC RCT TUM PROCTOTOMY TRANSSAC/TRANSCOCCYGEAL | 46 (<0.1%) | 31 (<0.1%) | 15 (<0.1%) | |
| EXC SACRAL PRESSURE ULC W/PRIM SUTR W/OSTECTOMY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXC TRCHNTRIC PR ULC MUSC/MYOQ FLAP/SKIN W/OSTC | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| EXC TRCHNTRIC PR ULCER W/PRIM SUTR W/OSTECTOMY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXC TUMOR SOFT TISSUE LEG/ANKLE SUBQ <3CM | 9 (<0.1%) | 5 (<0.1%) | 4 (<0.1%) | |
| EXC/DESTRUCTION OPEN ABDMNL TUMORS 5.1-10.0 CM | 698 (0.1%) | 380 (0.1%) | 318 (0.1%) | |
| EXC/DESTRUCTION OPEN ABDOMINAL TUMORS >10.0 CM | 1,305 (0.2%) | 707 (0.2%) | 598 (0.3%) | |
| EXCISION 1ST &/CERVICAL RIB | 45 (<0.1%) | 24 (<0.1%) | 21 (<0.1%) | |
| EXCISION 1ST &/CERVICAL RIB W/SYMPATHECTOMY | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| EXCISION AMPULLA VATER | 147 (<0.1%) | 82 (<0.1%) | 65 (<0.1%) | |
| EXCISION CHEST WALL TUMOR INCLUDING RIBS | 45 (<0.1%) | 31 (<0.1%) | 14 (<0.1%) | |
| EXCISION CHOLEDOCHAL CYST | 32 (<0.1%) | 23 (<0.1%) | 9 (<0.1%) | |
| EXCISION EXCESSIVE SKIN & SUBQ TISSUE ABDOMEN | 14 (<0.1%) | 14 (<0.1%) | 0 (0%) | |
| EXCISION GANGLION WRIST DORSAL/VOLAR PRIMARY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXCISION HYDROCELE BILATERAL | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| EXCISION HYDROCELE UNILATERAL | 10 (<0.1%) | 1 (<0.1%) | 9 (<0.1%) | |
| EXCISION INFECTED GRAFT ABDOMEN | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| EXCISION INFECTED GRAFT EXTREMITY | 22 (<0.1%) | 13 (<0.1%) | 9 (<0.1%) | |
| EXCISION INFECTED GRAFT THORAX | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXCISION INFECTED NECK GRAFT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXCISION ISCHIAL BURSA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXCISION LESION FLOOR MOUTH | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| EXCISION LESION MESENTERY SEPARATE PROCEDURE | 50 (<0.1%) | 27 (<0.1%) | 23 (<0.1%) | |
| EXCISION LESION PANCREAS | 469 (<0.1%) | 263 (<0.1%) | 206 (<0.1%) | |
| EXCISION LESION TENDON SHEATH/CAPSULE LEG&/ANK | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXCISION LESION TONGUE W/O CLOSURE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| EXCISION MALIGNANT TUMOR MANDIBLE | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| EXCISION MALIGNANT TUMOR MANDIBLE RADICAL | 5 (<0.1%) | 3 (<0.1%) | 2 (<0.1%) | |
| EXCISION OF PENILE PLAQUE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXCISION PAROTID TUMOR/GLAND TOTAL EN BLOC RMVL | 9 (<0.1%) | 2 (<0.1%) | 7 (<0.1%) | |
| EXCISION RIB PARTIAL | 19 (<0.1%) | 10 (<0.1%) | 9 (<0.1%) | |
| EXCISION SACRAL PRESSURE ULCER W/PRIMARY SUTURE | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| EXCISION SACRAL PRESSURE ULCER W/SKIN FLAP CLSR | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| EXCISION SKIN ABD INFRAUMBILICAL PANNICULECTOMY | 951 (0.2%) | 822 (0.3%) | 129 (<0.1%) | |
| EXCISION SUBMANDIBULAR SUBMAXILLARY GLAND | 15 (<0.1%) | 7 (<0.1%) | 8 (<0.1%) | |
| EXCISION SYNOVIAL CYST POPLITEAL SPACE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXCISION THYROGLOSSAL DUCT CYST/SINUS | 9 (<0.1%) | 6 (<0.1%) | 3 (<0.1%) | |
| EXCISION TRACHEAL TUMOR/CARCINOMA CERVICAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXCISION TROCHANTERIC BURSA/CALCIFICATION | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXCISION TUMOR SOFT TISSUE THIGH/KNEE SUBQ <3CM | 17 (<0.1%) | 8 (<0.1%) | 9 (<0.1%) | |
| EXCISION VAGINAL CYST/TUMOR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXCISION/CURETTAGE BONE CYST/TUMOR TIBIA/FIBULA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXCISION/CURETTAGE CYST/TUMOR FEMUR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXCISION/DESTRUCTION OPEN ABDOMINAL TUMOR 5 CM/< | 958 (0.2%) | 518 (0.2%) | 440 (0.2%) | |
| EXCISION/UNROOFING CYST KIDNEY | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| EXCLUSION SM INT FROM PELVIS MESH/PROSTH/TISS | 10 (<0.1%) | 5 (<0.1%) | 5 (<0.1%) | |
| EXPL CONGENITAL ATRESIA BILE DUCTS | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| EXPL N/FLWD SURG RPR W/WO LYSIS CAROTID ARTERY | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| EXPL N/FLWD SURG RPR W/WO LYSIS FEMORAL ARTERY | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| EXPL N/FLWD SURG RPR W/WO LYSIS OTHER ARTERY | 12 (<0.1%) | 4 (<0.1%) | 8 (<0.1%) | |
| EXPL PENETRATING WOUND SPX ABDOMEN/FLANK/BACK | 33 (<0.1%) | 18 (<0.1%) | 15 (<0.1%) | |
| EXPL PO HEMRRG THROMBOSIS/INFCTJ ABD | 15 (<0.1%) | 9 (<0.1%) | 6 (<0.1%) | |
| EXPL PO HEMRRG THROMBOSIS/INFCTJ CH | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| EXPL PO HEMRRG THROMBOSIS/INFCTJ NCK | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| EXPL PO HEMRRG THROMBOSIS/INFCTJ XTR | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| EXPL RETROPERITONEUM W/WO BX SPX | 123 (<0.1%) | 50 (<0.1%) | 73 (<0.1%) | |
| EXPL RPR & PRESACRAL DRG RECTAL INJ W/COLOSTOMY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXPL RPR & PRESACRAL DRG RECTAL INJURY | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| EXPL UNDESCENDED TSTIS INGUN/SCROTAL AREA | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| EXPL W/REMOVAL DEEP FOREIGN BODY FOREARM/WRIST | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| EXPLORATION PENETRATING WOUND SPX EXTREMITY | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| EXPLORATORY LAPAROTOMY CELIOTOMY W/WO BIOPSY SPX | 2,166 (0.4%) | 1,105 (0.3%) | 1,061 (0.5%) | |
| EXTERNAL DRAINAGE PSEUDOCYST OF PANCREAS OPEN | 23 (<0.1%) | 11 (<0.1%) | 12 (<0.1%) | |
| FASCIOTOMY ILIOTIBIAL OPEN | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| FLAP ISLAND PEDICLE ANATOMIC NAMED AXIAL ARTERY | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| FLAP NEUROVASCULAR PEDICLE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| FREE FASCIAL FLAP W/MICROVASCULAR ANASTOMOSIS | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| FREE JEJUNUM TRSF W/MICROVASC ANASTOMOSIS | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| FREE MUSCLE/MYOCUTANEOUS FLAP W/MVASC ANAST | 9 (<0.1%) | 2 (<0.1%) | 7 (<0.1%) | |
| FREE OMENTAL FLAP W/MICROVASCULAR ANAST | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| FREE SKIN FLAP W/MICROVASCULAR ANASTOMOSIS | 10 (<0.1%) | 3 (<0.1%) | 7 (<0.1%) | |
| FRMJ DIRECT/TUBE PEDICLE W/WO TR SCALP ARMS/LEGS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| FRMJ DIRECT/TUBED PEDICLE W/WO TRANSFER TRUNK | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| FTH/GFT FR W/DIR CLSR F/C/C/M/N/AX/G/H/F 20 CM/< | 8 (<0.1%) | 2 (<0.1%) | 6 (<0.1%) | |
| FTH/GFT FREE W/DIRECT CLOSURE N/E/E/L 20 SQ CM/< | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| FTH/GFT FREE W/DIRECT CLOSURE S/A/L 20 CM/< | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| FTH/GFT FREE W/DIRECT CLOSURE TRUNK 20 CM/< | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| GASTRIC RSTCV W/BYP W/SHORT LIMB 150 CM/< | 801 (0.1%) | 633 (0.2%) | 168 (<0.1%) | |
| GASTRIC RSTCV W/BYP W/SM INT RCNSTJ LIMIT ABSRPJ | 53 (<0.1%) | 46 (<0.1%) | 7 (<0.1%) | |
| GASTRIC RSTCV W/O BYP VERTICAL-BANDED GASTROPLY | 17 (<0.1%) | 13 (<0.1%) | 4 (<0.1%) | |
| GASTRIC RSTCV W/PRTL GASTRECTOMY 50-100 CM | 520 (<0.1%) | 387 (0.1%) | 133 (<0.1%) | |
| GASTRODUODENOSTOMY | 20 (<0.1%) | 12 (<0.1%) | 8 (<0.1%) | |
| GASTROJEJUNOSTOMY W/O VAGOTOMY | 536 (<0.1%) | 301 (<0.1%) | 235 (0.1%) | |
| GASTROJEJUNOSTOMY W/VAGOTOMY ANY TYPE | 25 (<0.1%) | 15 (<0.1%) | 10 (<0.1%) | |
| GASTRORRHAPHY SUTR PRF8 DUOL/GSTR ULCER WND/INJ | 115 (<0.1%) | 65 (<0.1%) | 50 (<0.1%) | |
| GASTROSTOMY OPN W/CONSTJ GSTR TUBE | 35 (<0.1%) | 18 (<0.1%) | 17 (<0.1%) | |
| GASTROTOMY W/EXPLORATION/FOREIGN BODY REMOVAL | 35 (<0.1%) | 27 (<0.1%) | 8 (<0.1%) | |
| GASTROTOMY W/SUTR RPR PRE-ESOPG/GASTRIC LAC | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| GASTROTOMY W/SUTURE REPAIR BLEEDING ULCER | 8 (<0.1%) | 5 (<0.1%) | 3 (<0.1%) | |
| GENIOPLASTY SLIDING OSTEOTOMY SINGLE PIECE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| GI RCNSTJ PREV ESPHG/EXCLUSION W/COLON SM INT | 12 (<0.1%) | 5 (<0.1%) | 7 (<0.1%) | |
| GI RCNSTJ PREV ESPHG/EXCLUSION W/STOMACH | 11 (<0.1%) | 8 (<0.1%) | 3 (<0.1%) | |
| GLOSSECTOMY <ONE-HALF TONGUE | 9 (<0.1%) | 5 (<0.1%) | 4 (<0.1%) | |
| GLOSSECTOMY HEMIGLOSSECTOMY | 9 (<0.1%) | 6 (<0.1%) | 3 (<0.1%) | |
| GLOSSECTOMY PRTL W/UNI RADICAL NECK DSJ | 10 (<0.1%) | 2 (<0.1%) | 8 (<0.1%) | |
| GLSSC COMPL/TOT W/WOTRACHS W/O RAD NECK DSJ | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| GLSSC COMPOSIT RESCJ FLOOR SUPRAHYOID NCK DSJ | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| GLSSC COMPOSIT W/RESCJ FLOOR & MANDIBULAR RESCJ | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| GRAFT BONE MANDIBLE | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| GRAFT DERMA-FAT-FASCIA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| GRAFT THIERSCH RCT INCONTINENCE &/PROLAPSE | 5 (<0.1%) | 4 (<0.1%) | 1 (<0.1%) | |
| GRF FACIAL NERVE PARALYSIS REGIONAL MUSCLE TR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| GSTR RSTCV OPN RMVL & RPLCMT SUBQ PORT | 5 (<0.1%) | 3 (<0.1%) | 2 (<0.1%) | |
| GSTR RSTCV PX OPN REVJ SUBQ PORT COMPONENT ONLY | 11 (<0.1%) | 11 (<0.1%) | 0 (0%) | |
| GSTR RSTCV PX OPN RMVL SUBQ PORT COMPONENT ONLY | 9 (<0.1%) | 9 (<0.1%) | 0 (0%) | |
| GSTR RSTCV W/O BYP OTH/THN VER-BANDED GSTP | 171 (<0.1%) | 131 (<0.1%) | 40 (<0.1%) | |
| GSTRCT PRTL DSTL W/FRMJ INTSTINAL POUCH | 44 (<0.1%) | 22 (<0.1%) | 22 (<0.1%) | |
| GSTRCT PRTL DSTL W/GASTRODUODENOSTOMY | 567 (0.1%) | 311 (<0.1%) | 256 (0.1%) | |
| GSTRCT PRTL DSTL W/GASTROJEJUNOSTOMY | 1,124 (0.2%) | 559 (0.2%) | 565 (0.3%) | |
| GSTRCT PRTL DSTL W/ROUX-EN-Y RCNSTJ | 1,117 (0.2%) | 599 (0.2%) | 518 (0.2%) | |
| GSTRCT TOT W/ESOPHAGOENTEROSTOMY | 178 (<0.1%) | 83 (<0.1%) | 95 (<0.1%) | |
| GSTRCT TOT W/FRMJ INTSTINAL POUCH ANY TYPE | 86 (<0.1%) | 35 (<0.1%) | 51 (<0.1%) | |
| GSTRCT TOT W/ROUX-EN-Y RCNSTJ | 838 (0.2%) | 366 (0.1%) | 472 (0.2%) | |
| GSTRT W/ESOPHGL DILAT&INSJ PRM INTRAL TUBE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| HEMIARTHROPLASTY HIP PARTIAL | 8 (<0.1%) | 7 (<0.1%) | 1 (<0.1%) | |
| HEMORRHOIDOPEXY STAPLING | 65 (<0.1%) | 30 (<0.1%) | 35 (<0.1%) | |
| HEPATCOTOMY/HEPATCOSTOMY W/EXPL DRG/RMVL ST1 | 8 (<0.1%) | 4 (<0.1%) | 4 (<0.1%) | |
| HEPATECTOMY RESCJ PARTIAL LOBECTOMY | 13,556 (2.5%) | 6,770 (2.1%) | 6,786 (3.1%) | |
| HEPATECTOMY RESCJ TOTAL LEFT LOBECTOMY | 1,785 (0.3%) | 917 (0.3%) | 868 (0.4%) | |
| HEPATECTOMY RESCJ TOTAL RIGHT LOBECTOMY | 3,119 (0.6%) | 1,479 (0.5%) | 1,640 (0.8%) | |
| HEPATECTOMY RESCJ TRISEGMENTECTOMY | 1,512 (0.3%) | 734 (0.2%) | 778 (0.4%) | |
| HEPATOTOMY OPEN DRAINAGE ABSCESS/CYST 1/2 STAGES | 54 (<0.1%) | 39 (<0.1%) | 15 (<0.1%) | |
| HYOID MYOTOMY & SUSPENSION | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| HYPOPHYSEC/EXC PITUITARY TUM TRANSNASAL/SEPTAL | 9 (<0.1%) | 5 (<0.1%) | 4 (<0.1%) | |
| I&D ABSC RTRPHRNGL/PARAPHARYNGEAL XTRNL APPR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| I&D BELOW FASCIA FOOT 1 BURSAL SPACE | 26 (<0.1%) | 11 (<0.1%) | 15 (<0.1%) | |
| I&D BELOW FASCIA FOOT MULTIPLE AREAS | 5 (<0.1%) | 4 (<0.1%) | 1 (<0.1%) | |
| I&D DEEP ABSC BURSA/HEMATOMA THIGH/KNEE REGION | 40 (<0.1%) | 20 (<0.1%) | 20 (<0.1%) | |
| I&D DEEP ABSC/HMTMA SOFT TISSUE NECK/THORAX | 23 (<0.1%) | 12 (<0.1%) | 11 (<0.1%) | |
| I&D DEEP ABSCESS PST SPINE CRV THRC/CERVICOTHR | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| I&D DP ABSC/HMTMA SOFT TISS NCK/THORAX PRTL RI | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| I&D DP SUPRALEVATOR PELVIRCT/RETRORCT ABSC | 24 (<0.1%) | 7 (<0.1%) | 17 (<0.1%) | |
| I&D INTRAMURAL IM/ABSC TRANSANAL ANES | 39 (<0.1%) | 7 (<0.1%) | 32 (<0.1%) | |
| I&D ISCHIORCT/INTRAMURAL ABSC W/WO SETON | 109 (<0.1%) | 35 (<0.1%) | 74 (<0.1%) | |
| I&D ISCHIORECTAL&/PERIRECTAL ABSCESS SPX | 400 (<0.1%) | 127 (<0.1%) | 273 (0.1%) | |
| I&D PELVIS/HIP JT AREA DEEP ABSCESS/HEMATOMA | 20 (<0.1%) | 13 (<0.1%) | 7 (<0.1%) | |
| I&D SHOULDER DEEP ABSCESS/HEMATOMA | 7 (<0.1%) | 3 (<0.1%) | 4 (<0.1%) | |
| I&D SHOULDER INFECTED BURSA | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| I&D SOFT TISSUE ABSCESS SUBFASC | 70 (<0.1%) | 34 (<0.1%) | 36 (<0.1%) | |
| I&D SUBMUCOSAL ABSCESS RECTUM | 20 (<0.1%) | 7 (<0.1%) | 13 (<0.1%) | |
| I&D VULVA/PERINEAL ABSCESS | 32 (<0.1%) | 21 (<0.1%) | 11 (<0.1%) | |
| ILEOSTOMY/JEJUNOSTOMY NON-TUBE | 481 (<0.1%) | 256 (<0.1%) | 225 (0.1%) | |
| ILIAC ART EXPOS PROSTH/ILIAC OCCLS EVASC UNI | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| IMBRICATION DIAPHRAGM EVENTRATION | 13 (<0.1%) | 5 (<0.1%) | 8 (<0.1%) | |
| IMMT INSJ BRST PROSTH FLWG MASTOPEXY MAST/RCNSTJ | 120 (<0.1%) | 120 (<0.1%) | 0 (0%) | |
| IMPLANT MESH OPN HERNIA RPR/DEBRIDEMENT CLOSURE | 435 (<0.1%) | 257 (<0.1%) | 178 (<0.1%) | |
| IMPLNT BIO IMPLNT FOR SOFT TISSUE REINFORCEMENT | 23 (<0.1%) | 20 (<0.1%) | 3 (<0.1%) | |
| IN-SITU FEM-ANT TIBL PST TIBL/PRONEAL ART | 33 (<0.1%) | 8 (<0.1%) | 25 (<0.1%) | |
| IN-SITU VEIN BYP POP-TIBL PRONEAL | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| IN-SITU VEIN BYPASS FEMORAL-POPLITEAL | 41 (<0.1%) | 14 (<0.1%) | 27 (<0.1%) | |
| INC IMPLTJ PERIPH NERVE NEUROSTIMULATOR ELTRD | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| INCISION & DRAINAGE LEG/ANKLE ABSCESS/HEMATOMA | 58 (<0.1%) | 18 (<0.1%) | 40 (<0.1%) | |
| INCISION & DRAINAGE LEG/ANKLE INFECTED BURSA | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| INCISION AND DRAINAGE APPENDICEAL ABSCESS OPEN | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| INCISION DEEP BONE CORTEX FOREARM&/WRIST | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INCISION DEEP OPENING BONE CORTEX THORAX | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| INCISION EXTENSOR TENDON SHEATH WRIST | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INFRATEMPORAL MID CRANIAL FOSSA W/WO DISARTICLTN | 13 (<0.1%) | 0 (0%) | 13 (<0.1%) | |
| INGUINOFEM LMPHADEC SUPFC W/CLOQUETS NODE SPX | 154 (<0.1%) | 74 (<0.1%) | 80 (<0.1%) | |
| INGUINOFEM LMPHADEC SUPFC W/PEL LMPHADEC | 159 (<0.1%) | 74 (<0.1%) | 85 (<0.1%) | |
| INS INTRVAS VC FILTR W/WO VAS ACS VSL SELXN RS&I | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| INSERTION PERITONEAL-VENOUS SHUNT | 16 (<0.1%) | 11 (<0.1%) | 5 (<0.1%) | |
| INSERTION TISSUE EXPANDER INCL SBSQ XPNSJ | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INSERTION TUNNEL INTRAPERITONEAL CATH DIAL OPEN | 48 (<0.1%) | 18 (<0.1%) | 30 (<0.1%) | |
| INSERTION TUNNEL INTRAPERITONEAL CATH SUBQ PORT | 10 (<0.1%) | 2 (<0.1%) | 8 (<0.1%) | |
| INSJ GRAFT AORTA/GREAT VESSEL W/BYPASS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| INSJ INTRAPERITONEAL CATHETER W/IMG GUID | 19 (<0.1%) | 12 (<0.1%) | 7 (<0.1%) | |
| INSJ MESH/PROSTH PELVIC FLOOR DEFECT EACH SITE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INT ANAST PANCREATIC CYST GI TRACT DIRECT | 68 (<0.1%) | 29 (<0.1%) | 39 (<0.1%) | |
| INT ANAST PANCREATIC CYST GI TRACT ROUX-EN-Y | 68 (<0.1%) | 18 (<0.1%) | 50 (<0.1%) | |
| INTERPELVIABDOMINAL AMPUTATION | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| INTERSEX SURG MALE FEMALE | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| INTERTHORACOSCAPULAR AMPUTATION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INTESTINAL PLICATION SEPARATE PROCEDURE | 11 (<0.1%) | 9 (<0.1%) | 2 (<0.1%) | |
| INTRACRANIAL ARVEN MALFRMJ INFRATENTRL CMPL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INTRACRANIAL ARVEN MALFRMJ SUPRATENTRL CMPL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| INTRACRANIAL ARVEN MALFRMJ SUPRATENTRL SMPL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INTRAORAL I&D TONGUE/FLOOR MASTICATOR SPACE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| INTRAORAL I&D TONGUE/FLOOR SUBMNDBLR SPACE | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| INTSTINAL STRICTUROPLASTY W/WO DILAT OBSTRCJ | 87 (<0.1%) | 57 (<0.1%) | 30 (<0.1%) | |
| LAM BX/EXC ISPI NEO IDRL XMED CERVICAL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAM BX/EXC ISPI NEO IDRL XMED LUMBAR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAM EXC ISPI LES OTH/THN NEO IDRL LUMBAR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAM EXC/EVAC ISPI LESION OTH/THN NEO XDRL LUMBAR | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAM FACETECTOMY & FORAMOTOMY 1 SEGMENT CERVICAL | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LAM FACETECTOMY & FORAMOTOMY 1 SEGMENT LUMBAR | 57 (<0.1%) | 28 (<0.1%) | 29 (<0.1%) | |
| LAM FACETECTOMY & FORAMOTOMY 1 SEGMENT THORACIC | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LAM FACETECTOMY&FORAMTOMY 1 SGM EA CRV THRC/LMBR | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAM W/O FACETEC FORAMOT/DSKC 1/2 VRT SEG CRV | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAMINECTOMY BX/EXC ISPI NEO XDRL THORACIC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAMINECTOMY W/O FFD > 2 VERT SEG CERVICAL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAMINECTOMY W/O FFD > 2 VERT SEG LUMBAR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LAMINECTOMY W/O FFD 1/2 VERT SEG LUMBAR | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| LAMINECTOMY W/O FFD 1/2 VERT SEG THORACIC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAMINECTOMY W/RMVL ABNORMAL FACETS LUMBAR | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAMINECTOMY W/SECTION SPINAL ACCESSORY NERVE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LAMNOTMY INCL W/DCMPRSN NRV ROOT 1 INTRSPC CERVC | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAMNOTMY INCL W/DCMPRSN NRV ROOT 1 INTRSPC LUMBR | 33 (<0.1%) | 16 (<0.1%) | 17 (<0.1%) | |
| LAMOP CERVICAL W/DCMPRN SPI CORD 2/> VERT SEG | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAMOPLASTY CERVICAL DCMPRN CORD 2/> SEG RCNSTJ | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| LAMOT PRTL FFD EXC DISC REEXPL 1 NTRSPC CERVICAL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LAMOT PRTL FFD EXC DISC REEXPL 1 NTRSPC LUMBAR | 6 (<0.1%) | 1 (<0.1%) | 5 (<0.1%) | |
| LAP RPR HRNA XCPT INCAL/INGUN NCRC8/STRANGULATED | 1,363 (0.3%) | 753 (0.2%) | 610 (0.3%) | |
| LAPAROSCOPIC APPENDECTOMY | 4,715 (0.9%) | 2,410 (0.7%) | 2,305 (1.1%) | |
| LAPAROSCOPIC SURGICAL SPLENECTOMY | 1,227 (0.2%) | 708 (0.2%) | 519 (0.2%) | |
| LAPAROSCOPY ADRENALECTOMY PRTL/COMPL TABDL | 2,145 (0.4%) | 1,311 (0.4%) | 834 (0.4%) | |
| LAPAROSCOPY COLECTOMY PARTIAL W/ANASTOMOSIS | 39,816 (7.4%) | 20,831 (6.4%) | 18,985 (8.8%) | |
| LAPAROSCOPY COLPOPEXY SUSPENSION VAGINAL APEX | 10 (<0.1%) | 10 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY ENTEROLYSIS SEPARATE PROCEDURE | 1,036 (0.2%) | 716 (0.2%) | 320 (0.1%) | |
| LAPAROSCOPY FULGURATION OVIDUCTS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY NEPHRECTOMY W/PARTIAL URETERECT | 354 (<0.1%) | 177 (<0.1%) | 177 (<0.1%) | |
| LAPAROSCOPY NEPHRECTOMY W/TOTAL URETERECTOMY | 55 (<0.1%) | 28 (<0.1%) | 27 (<0.1%) | |
| LAPAROSCOPY PROCTOPEXY PROLAPSE | 1,192 (0.2%) | 1,102 (0.3%) | 90 (<0.1%) | |
| LAPAROSCOPY PROCTOPEXY PROLAPSE SIGMOID RESCJ | 644 (0.1%) | 554 (0.2%) | 90 (<0.1%) | |
| LAPAROSCOPY RADICAL NEPHRECTOMY | 152 (<0.1%) | 70 (<0.1%) | 82 (<0.1%) | |
| LAPAROSCOPY REPAIR INCISIONAL HERNIA REDUCIBLE | 3,541 (0.7%) | 2,019 (0.6%) | 1,522 (0.7%) | |
| LAPAROSCOPY SMALL INTESTINE RESCJ & ANASTOMOSIS | 24 (<0.1%) | 8 (<0.1%) | 16 (<0.1%) | |
| LAPAROSCOPY SUPRACERVICAL HYSTERECTOMY 250 GM/< | 5 (<0.1%) | 5 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY SURG ABLATION RENAL CYSTS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LAPAROSCOPY SURG CHOLECYSTECTOMY | 11,690 (2.2%) | 7,633 (2.4%) | 4,057 (1.9%) | |
| LAPAROSCOPY SURG CHOLECYSTOENETEROSTOMY | 8 (<0.1%) | 6 (<0.1%) | 2 (<0.1%) | |
| LAPAROSCOPY SURG COLOSTOMY/SKN LVL CECOSTOMY | 1,611 (0.3%) | 833 (0.3%) | 778 (0.4%) | |
| LAPAROSCOPY SURG ILEOSTOMY/JEJUNOSTOMY NON-TUBE | 646 (0.1%) | 363 (0.1%) | 283 (0.1%) | |
| LAPAROSCOPY SURG PARTIAL NEPHRECTOMY | 75 (<0.1%) | 35 (<0.1%) | 40 (<0.1%) | |
| LAPAROSCOPY SURG PYELOPLASTY | 11 (<0.1%) | 6 (<0.1%) | 5 (<0.1%) | |
| LAPAROSCOPY SURG RPR INITIAL INGUINAL HERNIA | 1,974 (0.4%) | 246 (<0.1%) | 1,728 (0.8%) | |
| LAPAROSCOPY SURG W/BX SINGLE/MULTIPLE | 648 (0.1%) | 331 (0.1%) | 317 (0.1%) | |
| LAPAROSCOPY TOT HYSTERECTOMY >250 G W/TUBE/OVAR | 16 (<0.1%) | 16 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY TOTAL HYSTERECTOMY UTERUS >250 GM | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY W TOTAL HYSTERECTOMY UTERUS 250 GM/< | 8 (<0.1%) | 8 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY W TOTAL HYSTERECTOMY UTERUS 250 GM/> | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY W/LYSIS OF ADHESIONS | 10 (<0.1%) | 7 (<0.1%) | 3 (<0.1%) | |
| LAPAROSCOPY W/PLMT OCCLUSION DEVICE OVIDUCTS | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LAPAROSCOPY W/RMVL ADNEXAL STRUCTURES | 39 (<0.1%) | 38 (<0.1%) | 1 (<0.1%) | |
| LAPS ABLTJ RENAL MASS LESION W/INTRAOP US | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LAPS BI TOT PEL LMPHADEC & PRI-AORTIC LYMPH BX 1 | 17 (<0.1%) | 13 (<0.1%) | 4 (<0.1%) | |
| LAPS CLSR NTRSTM LG/SM INT W/RESCJ & ANASTOMOSIS | 2,641 (0.5%) | 1,248 (0.4%) | 1,393 (0.6%) | |
| LAPS COLCT TTL ABD W/PRCTECT ILEOANAL ANASTOMSIS | 1,376 (0.3%) | 629 (0.2%) | 747 (0.3%) | |
| LAPS COLECTMY PRTL W/COLOPXTSTMY LW ANAST W/CLST | 2,341 (0.4%) | 1,019 (0.3%) | 1,322 (0.6%) | |
| LAPS COLECTOMY ABDL W/PROCTECTOMY W/ILEOSTOMY | 1,256 (0.2%) | 634 (0.2%) | 622 (0.3%) | |
| LAPS COLECTOMY PRTL W/COLOPXTSTMY LW ANAST | 31,821 (5.9%) | 16,234 (5.0%) | 15,587 (7.2%) | |
| LAPS COLECTOMY PRTL W/END CLST & CLSR DSTL SGM | 1,291 (0.2%) | 713 (0.2%) | 578 (0.3%) | |
| LAPS COLECTOMY PRTL W/RMVL TERMINAL ILEUM | 23,916 (4.4%) | 12,834 (4.0%) | 11,082 (5.1%) | |
| LAPS COLECTOMY TOT W/O PRCTECT W/ILEOST/ILEOPXTS | 3,654 (0.7%) | 1,925 (0.6%) | 1,729 (0.8%) | |
| LAPS ENTERECT RESCJ 1 SMALL INTEST RESCJ & ANA | 1,578 (0.3%) | 843 (0.3%) | 735 (0.3%) | |
| LAPS ESOPHAGOMYOTOMY W/FUNDOPLASTY IF PERFORMED | 1,283 (0.2%) | 683 (0.2%) | 600 (0.3%) | |
| LAPS ESOPHGL SPHNCTR AGMNTJ PLMT DEV CRRPL | 45 (<0.1%) | 18 (<0.1%) | 27 (<0.1%) | |
| LAPS FULG/EXC OVARY VISCERA/PERITONEAL SURFACE | 30 (<0.1%) | 28 (<0.1%) | 2 (<0.1%) | |
| LAPS GASTRIC RESTRICTIVE PROCEDURE PLACE DEVICE | 254 (<0.1%) | 190 (<0.1%) | 64 (<0.1%) | |
| LAPS GASTRIC RESTRICTIVE PX REMOVE DEVICE | 207 (<0.1%) | 175 (<0.1%) | 32 (<0.1%) | |
| LAPS GASTRIC RESTRICTIVE PX REMOVE DEVICE & PORT | 1,147 (0.2%) | 961 (0.3%) | 186 (<0.1%) | |
| LAPS GASTRIC RESTRICTIVE PX REMOVE&RPLCMT DEVICE | 25 (<0.1%) | 22 (<0.1%) | 3 (<0.1%) | |
| LAPS GASTRIC RESTRICTIVE PX REVISION DEVICE | 43 (<0.1%) | 39 (<0.1%) | 4 (<0.1%) | |
| LAPS GSTR RSTCV PX W/BYP ROUX-EN-Y LIMB <150 CM | 30,030 (5.6%) | 24,461 (7.5%) | 5,569 (2.6%) | |
| LAPS GSTR RSTCV PX W/BYP&SM INT RCNSTJ | 551 (0.1%) | 438 (0.1%) | 113 (<0.1%) | |
| LAPS GSTRC RSTRICTIV PX LONGITUDINAL GASTRECTOMY | 60,124 (11%) | 47,710 (15%) | 12,414 (5.7%) | |
| LAPS INSERTION TUNNELED INTRAPERITONEAL CATHETER | 264 (<0.1%) | 121 (<0.1%) | 143 (<0.1%) | |
| LAPS MOBLJ SPLENIC FLXR PFRMD W/PRTL COLECTOMY | 304 (<0.1%) | 147 (<0.1%) | 157 (<0.1%) | |
| LAPS MYOMECTOMY EXC 1-4 MYOMAS 250 GM/< | 5 (<0.1%) | 5 (<0.1%) | 0 (0%) | |
| LAPS MYOMECTOMY EXC 5/> MYOMAS >250 GRAMS | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LAPS PROCTECTOMY ABDOMINOPERINEAL W/COLOSTOMY | 3,570 (0.7%) | 1,475 (0.5%) | 2,095 (1.0%) | |
| LAPS PROCTECTOMY COMBINED PULL-THRU W/RESERVOIR | 2,115 (0.4%) | 859 (0.3%) | 1,256 (0.6%) | |
| LAPS PROSTECT RETROPUBIC RAD W/NRV SPARING ROBOT | 194 (<0.1%) | 3 (<0.1%) | 191 (<0.1%) | |
| LAPS REPAIR HERNIA EXCEPT INCAL/INGUN REDUCIBLE | 3,362 (0.6%) | 1,882 (0.6%) | 1,480 (0.7%) | |
| LAPS RPR INCISIONAL HERNIA NCRC8/STRANGULATED | 1,473 (0.3%) | 940 (0.3%) | 533 (0.2%) | |
| LAPS RPR PARAESPHGL HRNA INCL FUNDPLSTY W/MESH | 3,795 (0.7%) | 2,821 (0.9%) | 974 (0.4%) | |
| LAPS RPR PARAESPHGL HRNA INCL FUNDPLSTY W/O MESH | 5,756 (1.1%) | 4,252 (1.3%) | 1,504 (0.7%) | |
| LAPS RPR RECURRENT INCAL HRNA NCRC8/STRANGULATED | 569 (0.1%) | 347 (0.1%) | 222 (0.1%) | |
| LAPS RPR RECURRENT INCISIONAL HERNIA REDUCIBLE | 874 (0.2%) | 496 (0.2%) | 378 (0.2%) | |
| LAPS SUPRACRV HYSTEREC >250 G RMVL TUBE/OVARY | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| LAPS SUPRACRV HYSTERECT 250 GM/< RMVL TUBE/OVAR | 18 (<0.1%) | 18 (<0.1%) | 0 (0%) | |
| LAPS SURG ABLTJ 1 > LVR TUM CRYOSURG | 5 (<0.1%) | 3 (<0.1%) | 2 (<0.1%) | |
| LAPS SURG ABLTJ 1/> LVR TUM RF | 434 (<0.1%) | 153 (<0.1%) | 281 (0.1%) | |
| LAPS SURG BILATERAL TOTAL PELVIC LMPHADECTOMY | 18 (<0.1%) | 10 (<0.1%) | 8 (<0.1%) | |
| LAPS SURG CHOLECSTC W/EXPL COMMON DUCT | 181 (<0.1%) | 128 (<0.1%) | 53 (<0.1%) | |
| LAPS SURG CHOLECYSTECTOMY W/CHOLANGIOGRAPHY | 4,130 (0.8%) | 2,733 (0.8%) | 1,397 (0.6%) | |
| LAPS SURG ESOPG/GSTR FUNDOPLASTY | 3,235 (0.6%) | 2,130 (0.7%) | 1,105 (0.5%) | |
| LAPS SURG RETROPERITONEAL LYMPH NODE BX 1/MLT | 102 (<0.1%) | 48 (<0.1%) | 54 (<0.1%) | |
| LAPS SURG RPR RECURRENT INGUINAL HERNIA | 315 (<0.1%) | 35 (<0.1%) | 280 (0.1%) | |
| LAPS SURG TRNSXJ VAGUS NRV SLCTV/HILY SLCTV | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| LAPS SURG TRNSXJ VAGUS NRV TRUNCAL | 6 (<0.1%) | 5 (<0.1%) | 1 (<0.1%) | |
| LAPS SURG W/ASPIR CAVITY/CYST SINGLE/MULTIPLE | 65 (<0.1%) | 46 (<0.1%) | 19 (<0.1%) | |
| LAPS SURG W/DRG LYMPHOCELE PRTL CAVITY | 8 (<0.1%) | 4 (<0.1%) | 4 (<0.1%) | |
| LAPS SURG W/GID TRANSHEPATC CHOLANGRPH W/BX | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| LAPS SURG W/GID TRANSHEPATC CHOLANGRPH W/O BX | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| LAPS TOT HYSTERECTOMY RESJ MALIGNANCY W/OMNTC | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| LAPS TOTAL HYSTERECT 250 GM/< W/RMVL TUBE/OVARY | 133 (<0.1%) | 133 (<0.1%) | 0 (0%) | |
| LAPS URTRONEOCSTOST W/CSTSC&URTRL STENT PLMT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LAPS VAGINAL HYSTERECT > 250 GM RMVL TUBE&/OVAR | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| LAPS VAGINAL HYSTERECTOMY UTERUS 250 GM/< | 8 (<0.1%) | 8 (<0.1%) | 0 (0%) | |
| LAPS W/BI TOT PEL LMPHADEC & OMNTC LYMPH BX | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LAPS W/RAD HYST W/BILAT LMPHADEC RMVL TUBE/OVARY | 21 (<0.1%) | 21 (<0.1%) | 0 (0%) | |
| LAPS W/REVISION INTRAPERITONEAL CATHETER | 49 (<0.1%) | 28 (<0.1%) | 21 (<0.1%) | |
| LAPS W/VAG HYSTERECT 250 GM/&RMVL TUBE&/OVARIES | 32 (<0.1%) | 32 (<0.1%) | 0 (0%) | |
| LAPS W/VAGINAL HYSTERECTOMY > 250 GRAMS | 5 (<0.1%) | 5 (<0.1%) | 0 (0%) | |
| LAPT RPR PARAESOPH HIATAL HERNIA W/MESH | 265 (<0.1%) | 186 (<0.1%) | 79 (<0.1%) | |
| LAPT STG/RESTG OVARIAN TUBAL/PRIM MAL 2ND LOOK | 11 (<0.1%) | 10 (<0.1%) | 1 (<0.1%) | |
| LAPT W/ASPIR &/NJX HEPATC PARASITIC CYST/ABSCESS | 8 (<0.1%) | 7 (<0.1%) | 1 (<0.1%) | |
| LARYNGECTOMY TOTAL W/O RADICAL NECK DISSECTION | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| LARYNGECTOMY TOTAL W/RADICAL NECK DISSECTION | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| LASER ENUCLEATION PROSTATE W/MORCELLATION | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LASER VAPORIZATION OF PROSTATE FOR URINE FLOW | 8 (<0.1%) | 0 (0%) | 8 (<0.1%) | |
| LIG PRFRATR VEIN SUBFSCAL RAD INCL SKN GRF 1 LEG | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| LIG&DIV LONG SAPH VEIN SAPHFEM JUNCT/INTERRUPJ | 5 (<0.1%) | 3 (<0.1%) | 2 (<0.1%) | |
| LIG&TKDN SYSIC-TO-PULM ART SHUNT W/CGEN HEART | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LIG/BANDING ANGIOACCESS ARTERIOVENOUS FISTULA | 22 (<0.1%) | 8 (<0.1%) | 14 (<0.1%) | |
| LIG/STAPLING G-ESOP JUNCT PRE-ESOPHGL PRF8J | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| LIG/TRNSXJ FLP TUBE ABDL/VAG APPR UNI/BI | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LIGATION EXTERNAL CAROTID ARTERY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LIGATION MAJOR ARTERY ABDOMEN | 16 (<0.1%) | 4 (<0.1%) | 12 (<0.1%) | |
| LIGATION MAJOR ARTERY EXTREMITY | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| LIGATION OF COMMON ILIAC VEIN | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| LIGJ & DIV SHORT SAPH VEIN SAPHENOPOP JUNCT SPX | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| LIGJ DIVJ & STRIPPING SHORT SAPHENOUS VEIN | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| LIGJ DIVJ&STRIP LONG SAPH SAPHFEM JUNCT KNE/BELW | 26 (<0.1%) | 14 (<0.1%) | 12 (<0.1%) | |
| LMTD LMPHADEC STAGING SPX PEL&PARA-AORTIC | 40 (<0.1%) | 15 (<0.1%) | 25 (<0.1%) | |
| LMTD LMPHADEC STAGING SPX RPR AORTIC&/SPLENIC | 36 (<0.1%) | 18 (<0.1%) | 18 (<0.1%) | |
| LYMPHANGIOTOMY/OTH OPRATIONS LYMPHATIC CHANNELS | 7 (<0.1%) | 5 (<0.1%) | 2 (<0.1%) | |
| LYSIS OF ADHESIONS SALPINX/OVARY | 9 (<0.1%) | 7 (<0.1%) | 2 (<0.1%) | |
| MAJOR RECONSTRUCTION CHEST WALL POSTTRAUMATIC | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| MALAR AUGMENTATION PROSTHETIC MATERIAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| MAMMAPLASTY AUGMENTATION W/O PROSTHETIC IMPLANT | 10 (<0.1%) | 10 (<0.1%) | 0 (0%) | |
| MAMMAPLASTY AUGMENTATION W/PROSTHETIC IMPLANT | 10 (<0.1%) | 10 (<0.1%) | 0 (0%) | |
| MARSUPIALIZATION CST/ABSC LVR | 127 (<0.1%) | 100 (<0.1%) | 27 (<0.1%) | |
| MARSUPIALIZATION PANCREATIC CYST | 10 (<0.1%) | 8 (<0.1%) | 2 (<0.1%) | |
| MAST MODF RAD W/AX LYMPH NOD W/WO PECT/ALIS MIN | 5,116 (0.9%) | 5,023 (1.5%) | 93 (<0.1%) | |
| MAST RAD W/PECTORAL MUSC AX INT MAM LYMPH NODES | 59 (<0.1%) | 58 (<0.1%) | 1 (<0.1%) | |
| MAST RAD W/PECTORAL MUSCLES AXILLARY LYMPH NODES | 605 (0.1%) | 597 (0.2%) | 8 (<0.1%) | |
| MASTECTOMY GYNECOMASTIA | 47 (<0.1%) | 5 (<0.1%) | 42 (<0.1%) | |
| MASTECTOMY PARTIAL | 2,220 (0.4%) | 2,207 (0.7%) | 13 (<0.1%) | |
| MASTECTOMY PARTIAL W/AXILLARY LYMPHADENECTOMY | 845 (0.2%) | 832 (0.3%) | 13 (<0.1%) | |
| MASTECTOMY SIMPLE COMPLETE | 14,596 (2.7%) | 14,411 (4.4%) | 185 (<0.1%) | |
| MASTECTOMY SUBCUTANEOUS | 1,153 (0.2%) | 1,108 (0.3%) | 45 (<0.1%) | |
| MASTOPEXY | 18 (<0.1%) | 18 (<0.1%) | 0 (0%) | |
| MASTOTOMY W/EXPLORATION/DRAINAGE ABSCESS DEEP | 152 (<0.1%) | 146 (<0.1%) | 6 (<0.1%) | |
| MEDIAST W/EXPL DRG RMVL FB/BX TTHRC APPR | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| MEDIASTINOSCOPY INCL BIOPSIES WHEN PERFORMED | 22 (<0.1%) | 10 (<0.1%) | 12 (<0.1%) | |
| MGMT LVR HEMRRG CPLX SUTR WND/INJ | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| MGMT LVR HEMRRG EXPL WND DBRDMT COAGJ/SUTR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| MGMT LVR HEMRRG SMPL SUTR LVR WND/INJ | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| MOBLJ SPLENIC FLXR PFRMD CONJUNCT W/PRTL COLCT | 106 (<0.1%) | 51 (<0.1%) | 55 (<0.1%) | |
| MUSC MYOCUTANEOUS/FASCIOCUTANEOUS FLAP HEAD&NC | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| MUSC MYOCUTANEOUS/FASCIOCUTANEOUS FLAP LXTR | 148 (<0.1%) | 76 (<0.1%) | 72 (<0.1%) | |
| MUSC MYOCUTANEOUS/FASCIOCUTANEOUS FLAP TRUNK | 1,420 (0.3%) | 742 (0.2%) | 678 (0.3%) | |
| MUSC MYOCUTANEOUS/FASCIOCUTANEOUS FLAP UXTR | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| MUSC MYOQ/FSCQ FLAP HEAD&NECK W/NAMED VASC PEDCL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| MYOMECTOMY 1-4 MYOMAS W/250 GM/< ABDOMINAL APPR | 32 (<0.1%) | 32 (<0.1%) | 0 (0%) | |
| MYOMECTOMY 5/> MYOMAS &/>250 GM ABDOMINA | 21 (<0.1%) | 21 (<0.1%) | 0 (0%) | |
| NEPHRECTOMY PARTIAL | 50 (<0.1%) | 18 (<0.1%) | 32 (<0.1%) | |
| NEPHRECTOMY W/PRTL URETERECT OPEN RIB RESCJ RAD | 98 (<0.1%) | 42 (<0.1%) | 56 (<0.1%) | |
| NEPHRECTOMY W/PRTL URETERECT OPN RIB RESCJ COMPL | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| NEPHRECTOMY W/PRTL URETERECTOMY W/OPEN RIB RESCJ | 233 (<0.1%) | 122 (<0.1%) | 111 (<0.1%) | |
| NEPHRECTOMY W/TOT URETERECT&BLDR CUFF SAME INC | 29 (<0.1%) | 13 (<0.1%) | 16 (<0.1%) | |
| NEPHROLITHOTOMY REMOVAL STAGE 1 | 4 (<0.1%) | 0 (0%) | 4 (<0.1%) | |
| NERVE GRAFT HEAD/NECK >4 CM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| NEURP MAJOR PRPH NRV ARM/LEG OPN OTH/THN SPEC | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| NEURP MAJOR PRPH NRV OPN ARM/LEG BRACH PLEXUS | 12 (<0.1%) | 8 (<0.1%) | 4 (<0.1%) | |
| NEURP MAJOR PRPH NRV OPN ARM/LEG LMBR PLEXUS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| NEURP MAJOR PRPH NRV OPN ARM/LEG SCIATIC NRV | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| NIPPLE EXPLORATION | 19 (<0.1%) | 19 (<0.1%) | 0 (0%) | |
| NIPPLE/AREOLA RECONSTRUCTION | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| OMENTAL FLAP EXTRA-ABDOMINAL | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| OMENTAL FLAP INTRA-ABDOMINAL | 29 (<0.1%) | 14 (<0.1%) | 15 (<0.1%) | |
| OMNTC EPIPLOECTOMY RESCJ OMENTUM SPX | 98 (<0.1%) | 46 (<0.1%) | 52 (<0.1%) | |
| OOPHORECTOMY PARTIAL/TOTAL UNI/BI | 21 (<0.1%) | 21 (<0.1%) | 0 (0%) | |
| OOPHORECTOMY PRTL/TOT UNI/BI OVARIAN MALIGNANCY | 7 (<0.1%) | 7 (<0.1%) | 0 (0%) | |
| OPEN ABLATION RENAL MASS CRYOSURG ULTRASOUND | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN PERIPROSTHETIC CAPSULOTOMY BREAST | 6 (<0.1%) | 6 (<0.1%) | 0 (0%) | |
| OPEN REPAIR OF ROTATOR CUFF CHRONIC | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN TREATMENT BIMALLEOLAR ANKLE FRACTURE | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| OPEN TREATMENT GREATER TROCHANTERIC FRACTURE | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| OPEN TREATMENT PROXIMAL HUMERAL FRACTURE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN TREATMENT RADIAL SHAFT FRACTURE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OPEN TX CARPAL SCAPHOID NAVICULAR FRACTURE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OPEN TX COMP FX MALAR W/INTERNAL FX&MULT SURG | 4 (<0.1%) | 0 (0%) | 4 (<0.1%) | |
| OPEN TX CRANIOFACIAL SEP COMP W/INT&/XTRNL FIX | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN TX DISTAL FIBULAR FRACTURE LAT MALLEOLUS | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| OPEN TX DISTAL TIBIOFIBULAR JOINT DISRUPTION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN TX FEMORAL FRACTURE DISTAL MED/LAT CONDYLE | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| OPEN TX HUMERAL SUPRACONDYLAR FRACTURE W/XTN | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OPEN TX MANDIBULAR FX W/INTERDENTAL FIXATION | 13 (<0.1%) | 2 (<0.1%) | 11 (<0.1%) | |
| OPEN TX MANDIBULAR FX W/O INTERDENTAL FIXATION | 4 (<0.1%) | 0 (0%) | 4 (<0.1%) | |
| OPEN TX METACARPAL FRACTURE SINGLE EA BONE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| OPEN TX ORBITAL FLOOR BLOWOUT FX TRANSANTRAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN TX PALATAL/MAXILLARY FX COMP MULTIPLE APPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPEN TX RADIAL&ULNAR SHAFT FX W/FIXJ RADIUS/ULNA | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| OPEN TX RIB FX W/FIXJ THORACOSCOPIC VIS 1-3 RIBS | 17 (<0.1%) | 7 (<0.1%) | 10 (<0.1%) | |
| OPEN TX STERNUM FRACTURE W/WO SKELETAL FIXATION | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| OPEN TX TIBIAL FRACTURE PROXIMAL UNICONDYLAR | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| OPEN TX TRIMALLEOLAR ANKLE FX W/O FIXJ PST LIP | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| OPN FEM ART EXPOS DLVR EVASC PROSTH UNI | 27 (<0.1%) | 6 (<0.1%) | 21 (<0.1%) | |
| OPN RPR ARYSM RPR ARTL TRAUMA TUBE PROSTH | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| OPN RPR ARYSM RPR ARTL TRMA AORTO-BIFEM PROSTH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OPN RPR ARYSM RPR ARTL TRMA AORTOBIILIAC PROSTH | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| OPTX COMP MANDIBULAR FX MLT APPR W/INT FIXATION | 5 (<0.1%) | 1 (<0.1%) | 4 (<0.1%) | |
| OPTX DSTL RADL I-ARTIC FX/EPIPHYSL SEP 3 FRAG | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPTX FEM FX PROX END NCK INT FIXJ/PROSTC RPLCMT | 8 (<0.1%) | 4 (<0.1%) | 4 (<0.1%) | |
| OPTX FEM SHFT FX W/PLATE/SCREWS W/WO CERCLAGE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OPTX HUMERAL SHFT FX W/PLATE/SCREWS W/WOCERCLAGE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| OPTX ORB FLOOR BLWT FX PRI/BITAL APPR W/ALLPLSTC | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| OPTX PATLLR FX W/INT FIXJ/PATLLC&SOFT TISS RPR | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| OPTX&/RDCTJ VRT FX&/DISLC PST 1 VRT SGM CR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| ORCHIECTOMY PARTIAL | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| ORCHIECTOMY RADICAL TUMOR INGUINAL APPROACH | 12 (<0.1%) | 0 (0%) | 12 (<0.1%) | |
| ORCHIECTOMY RADICAL TUMOR W/ABDOMINAL EXPL | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| ORCHIECTOMY SIMPLE SCROTAL/INGUINAL APPROACH | 5 (<0.1%) | 1 (<0.1%) | 4 (<0.1%) | |
| ORCHIOPEXY INGUINAL APPROACH W/WO HERNIA RPR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTECTOMY STERNUM PARTIAL | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| OSTEOPLASTY FACIAL BONES AUGMENTATION | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOPLASTY TIBIA & FIBULA LENGTHENING/SHORTENIN | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOT INTERTRCHNTRIC/SUBTRCHNTRIC W/INT/XTRNL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OSTEOT PROX TIBIA FIB EXC/OSTEOT BEFORE EPIPHYSL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOTOMY FEMUR SHAFT/SUPRACONDYLAR W/FIXATION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OSTEOTOMY PELVIS BILATERAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOTOMY SPINE PST/PSTLAT APPR 1 VRT SGM CRV | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOTOMY SPINE PST/PSTLAT APPR 1 VRT SGM LMBR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOTOMY SPINE PST/PSTLAT APPR 1 VRT SGM THRC | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| OSTEOTOMY TIBIA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| OSTEOTOMY TIBIA & FIBULA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| Other | 4,291 (0.8%) | 3,210 (1.0%) | 1,081 (0.5%) | |
| OVARIAN CYSTECTOMY UNI/BI | 16 (<0.1%) | 16 (<0.1%) | 0 (0%) | |
| PALATOP CL PALATE SOFT&/HARD PALATE ONLY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PALATOPHARYNGOPLASTY | 5 (<0.1%) | 1 (<0.1%) | 4 (<0.1%) | |
| PANCREATECTOMY TOTAL | 640 (0.1%) | 319 (<0.1%) | 321 (0.1%) | |
| PANCREATECTOMY W/TRNSPLJ PANCREAS/ISLET CELLS | 206 (<0.1%) | 127 (<0.1%) | 79 (<0.1%) | |
| PANCREATICOJEJUNOSTOMY SIDE-TO-SIDE ANAST | 212 (<0.1%) | 97 (<0.1%) | 115 (<0.1%) | |
| PARATHYRDEC/EXPL PARATHYR MEDSTNL STERNAL/TTHRC | 20 (<0.1%) | 11 (<0.1%) | 9 (<0.1%) | |
| PARATHYROID AUTOTRANSPLANTATION ADD-ON | 9 (<0.1%) | 7 (<0.1%) | 2 (<0.1%) | |
| PARATHYROIDECTOMY/EXPLOR PARATHYROIDS RE-EXPLOR | 108 (<0.1%) | 70 (<0.1%) | 38 (<0.1%) | |
| PARATHYROIDECTOMY/EXPLORATION PARATHYROIDS | 2,521 (0.5%) | 1,659 (0.5%) | 862 (0.4%) | |
| PARAVAGINAL DEFECT REPAIR LAPAROSCOPIC APPROACH | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PARAVAGINAL DEFECT REPAIR OPEN ABDOMINAL APPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PARAVAGINAL DEFECT REPAIR VAGINAL APPROACH | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PARTIAL EXCISION BONE FIBULA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PARTIAL EXCISION BONE SCAPULA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PARTIAL EXCISION BONE TIBIA | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PARTIAL EXCISION DEEP PELVIS | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| PARTIAL LARYNGECTOMY HEMILARYGECTOMY HORIZONTAL | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| PARTIAL LARYNGECTOMY HEMILARYNG LATEROVERTICAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PEL EXNTJ GYNECOLOGIC MAL | 20 (<0.1%) | 20 (<0.1%) | 0 (0%) | |
| PEL LMPHADEC W/XTRNL ILIAC HYPOGSTR&OBTURATOR | 48 (<0.1%) | 23 (<0.1%) | 25 (<0.1%) | |
| PELVIC EXENTERATION COLORECTAL MALIGNANCY | 435 (<0.1%) | 195 (<0.1%) | 240 (0.1%) | |
| PELVIC EXENTERATION COMPLETE MALIGNANCY | 55 (<0.1%) | 10 (<0.1%) | 45 (<0.1%) | |
| PERICARDIOTOMY REMOVAL CLOT/FOREIGN BODY PRIMARY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PERINEOPLASTY RPR PERINEUM NONOBSTETRICAL SPX | 5 (<0.1%) | 5 (<0.1%) | 0 (0%) | |
| PERIPROSTHETIC CAPSULECTOMY BREAST | 17 (<0.1%) | 17 (<0.1%) | 0 (0%) | |
| PHARYNGOLARYNGECTOMY W/RAD NECK DSJ W/O RCNSTJ | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| PHARYNGOPLASTY PLSTC/RCNSTV OPRATION PHARYNX | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| PLEURAL SCARIFICATION REPEAT PNEUMOTHORAX | 10 (<0.1%) | 4 (<0.1%) | 6 (<0.1%) | |
| PLMT DSTL XTN PROSTH DLYD AFTER EVASC RPR DTA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PLMT EXPANDABLE CATH BRST FOLLOWING PRTL MAST | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| PLMT PROX XTN PROSTH EVASC RPR DTA 1ST XTN | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PLMT VEIN PATCH/CUFF DSTL ANAST BYP CONDUIT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PLMT XTN PROSTH EVASC RPR ARYSM/DSJ 1ST VSL | 26 (<0.1%) | 5 (<0.1%) | 21 (<0.1%) | |
| PNCRTECT DSTL NR-TOT W/PRSRV DUO CHLD-TYP PX | 204 (<0.1%) | 105 (<0.1%) | 99 (<0.1%) | |
| PNCRTECT DSTL STOT W/O PNCRTCOJEJUNOSTOMY | 9,079 (1.7%) | 5,044 (1.6%) | 4,035 (1.9%) | |
| PNCRTECT DSTL STOT W/PNCRTCOJEJUNOSTOMY | 427 (<0.1%) | 218 (<0.1%) | 209 (<0.1%) | |
| PNCRTECT PROX STOT W/O PANCREATOJEJUNOSTOMY | 238 (<0.1%) | 117 (<0.1%) | 121 (<0.1%) | |
| PNCRTECT PROX STOT W/PANCREATOJEJUNOSTOMY | 11,340 (2.1%) | 5,097 (1.6%) | 6,243 (2.9%) | |
| PNCRTECT W/PANCREATOJEJUNOSTOMY | 6,262 (1.2%) | 3,020 (0.9%) | 3,242 (1.5%) | |
| PNCRTECT WHIPPLE W/O PANCREATOJEJUNOSTOMY | 484 (<0.1%) | 226 (<0.1%) | 258 (0.1%) | |
| PNEUMONOSTOMY W/OPEN DRAINAGE ABSCESS/CYST | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| POST COLPORRHAPHY RECTOCELE W/WO PERINEORRHAPHY | 28 (<0.1%) | 28 (<0.1%) | 0 (0%) | |
| POSTERIOR NON-SEGMENTAL INSTRUMENTATION | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| POSTERIOR SEGMENTAL INSTRUMENTATION 3-6 VRT SEG | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PRCTECT CMBN ABDOMINOPRNL PULL-THRU PX | 762 (0.1%) | 301 (<0.1%) | 461 (0.2%) | |
| PRCTECT CMBN PULL-THRU W/RSVR W/NTRSTM | 882 (0.2%) | 350 (0.1%) | 532 (0.2%) | |
| PRCTECT COMPL CMBN ABDOMINOPRNL W/CLST | 4,207 (0.8%) | 1,750 (0.5%) | 2,457 (1.1%) | |
| PRCTECT COMPL W/PULL-THRU PX & ANASTOMOSIS | 60 (<0.1%) | 28 (<0.1%) | 32 (<0.1%) | |
| PRCTECT COMPL W/STOT/TOT COLCT W/MLT BXS | 49 (<0.1%) | 26 (<0.1%) | 23 (<0.1%) | |
| PRCTECT PRTL RESCJ RECTUM TABDL APPR | 1,197 (0.2%) | 565 (0.2%) | 632 (0.3%) | |
| PRCTECT PRTL W/ANAST ABDL & TRANSSAC APPROACH | 110 (<0.1%) | 49 (<0.1%) | 61 (<0.1%) | |
| PRCTECT PRTL W/ANAST TRANSSAC APPR ONLY | 21 (<0.1%) | 9 (<0.1%) | 12 (<0.1%) | |
| PRCTECT PRTL W/MUCOSEC ILEOANAL ANAST RSVR | 1,049 (0.2%) | 432 (0.1%) | 617 (0.3%) | |
| PRCTECT PRTL W/O ANAST PRNL APPR | 412 (<0.1%) | 265 (<0.1%) | 147 (<0.1%) | |
| PRICARDIECTOMY STOT/COMPL W/O CARDPULM BYPASS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROCTOPEXY ABDOMINAL APPROACH | 430 (<0.1%) | 391 (0.1%) | 39 (<0.1%) | |
| PROCTOPEXY PERINEAL APPROACH | 134 (<0.1%) | 118 (<0.1%) | 16 (<0.1%) | |
| PROCTOPEXY W/SIGMOID RESCJ ABDL APPR | 343 (<0.1%) | 297 (<0.1%) | 46 (<0.1%) | |
| PROCTOPLASTY PROLAPSE MUCOUS MEMBRANE | 133 (<0.1%) | 97 (<0.1%) | 36 (<0.1%) | |
| PROPH TX N/P/PLTWR W/WO METHYLMETHACRYLATE FEMUR | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| PROPH TX N/P/PLTWR W/WO METHYLMETHACRYLATE TIBIA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROPH TX N/P/PLTWR W/WO MMA FEM NCK & PROX FEMUR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROSTATECTOMY PERINEAL RAD W/BI PELVIC LYMPH EXC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROSTATECTOMY PERINEAL RADICAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROSTATECTOMY PERINEAL RADICAL W/LYMPH NODE BX | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROSTATECTOMY PERINEAL SUBTOTAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PROSTATECTOMY RETROPUBIC SUBTOTAL | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| PROSTATECTOMY RETROPUBIC W/WO NERVE SPARING | 6 (<0.1%) | 0 (0%) | 6 (<0.1%) | |
| PROSTATECTOMY SUPRAPUBIC SUBTOTAL 1/2 STAGES | 5 (<0.1%) | 1 (<0.1%) | 4 (<0.1%) | |
| PROSTECT RETROPUB RAD W/WO NRV SPAR & BI PLV LYM | 14 (<0.1%) | 0 (0%) | 14 (<0.1%) | |
| PROSTECT RETROPUBIC RAD W/WO NRV SPAR W/LYMPH BX | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| PRTL ESOPH DSTL W/WO PROX GASTRC W/COLON NTRPSTJ | 16 (<0.1%) | 5 (<0.1%) | 11 (<0.1%) | |
| PRTL ESOPHAGEC W/WO PROX GASTREC/PYLOROPLASTY | 20 (<0.1%) | 3 (<0.1%) | 17 (<0.1%) | |
| PRTL ESOPHAGECTOMY CERVICAL W/FREE INTSTINAL GRF | 4 (<0.1%) | 0 (0%) | 4 (<0.1%) | |
| PRTL ESOPHECT DSTL W/WO PROX GASTRECT/PYLORPLSTY | 1,016 (0.2%) | 195 (<0.1%) | 821 (0.4%) | |
| PRTL ESOPHG THORACOABD W/WO PROXGASTREC/PYLOROPL | 267 (<0.1%) | 74 (<0.1%) | 193 (<0.1%) | |
| PRTL ESPHG THORACOABDL/ABDL APPR NTRPSTJ/RCNSTJ | 22 (<0.1%) | 9 (<0.1%) | 13 (<0.1%) | |
| PRTL EXC PST VRT INTRNSC B1Y LES 1 VRT SGM LMBR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PRTL EXC PST VRT INTRNSC B1Y LES 1 VRT SGM THRC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| PRTL EXC VRT BDY B1Y LES W/O SPI CORD 1 SGM LMBR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PRTL THYROID LOBEC UNI W/CONTRATLAT STOT LOBEC | 64 (<0.1%) | 53 (<0.1%) | 11 (<0.1%) | |
| PRTL THYROID LOBECTOMY UNI W/WO ISTHMUSECTOMY | 543 (0.1%) | 419 (0.1%) | 124 (<0.1%) | |
| PYELOPLASTY COMPLICATED | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PYELOPLASTY SIMPLE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| PYELOTOMY W/REMOVAL CALCULUS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| PYLOROMYOTOMY CUTTING PYLORIC MUSC | 21 (<0.1%) | 16 (<0.1%) | 5 (<0.1%) | |
| PYLOROPLASTY | 141 (<0.1%) | 98 (<0.1%) | 43 (<0.1%) | |
| RAD ABDL HYSTERECTOMY W/BI PELVIC LMPHADENECTOMY | 19 (<0.1%) | 19 (<0.1%) | 0 (0%) | |
| RAD RESCJ TUM SOFT TISSUE FOREARM&/WRIST 3 CM/> | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| RAD RESCT TUMOR ILIUM ACETABULUM BOTH PUBIC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RAD RESCT TUMOR ISCHIAL TUBEROSITY&GRT TRCHNTR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RAD RESCT TUMOR WING OF ILIUM 1 PUBIC/ISCHIAL | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| RAD RESECT TUMOR SOFT TISS FOREARM&/WRIST <3 CM | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| RAD RESECT TUMOR SOFT TISS UPPER ARM/ELBOW <5CM | 6 (<0.1%) | 4 (<0.1%) | 2 (<0.1%) | |
| RAD RESECT TUMOR SOFT TISSUE HAND/FINGER <3CM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RAD RESECT TUMOR SOFT TISSUE PELVIS & HIP <5 CM | 43 (<0.1%) | 25 (<0.1%) | 18 (<0.1%) | |
| RAD RESECT TUMOR SOFT TISSUE THIGH/KNEE <5CM | 23 (<0.1%) | 14 (<0.1%) | 9 (<0.1%) | |
| RAD RESECTION TUMOR SOFT TISSUE LEG/ANKLE <5CM | 19 (<0.1%) | 8 (<0.1%) | 11 (<0.1%) | |
| RADICAL RESCJ TONSIL CLOSURE W/LOCAL FLAP | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RADICAL RESECTION OF TUMOR TIBIA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RADICAL RESECTION TUMOR FEMOR OR KNEE | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| RADICAL RESECTION TUMOR SCAPULA | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| RCNSTJ MIDFACE LEFORT I 1 PIECE W/O BONE GRAFT | 8 (<0.1%) | 2 (<0.1%) | 6 (<0.1%) | |
| RCNSTJ MIDFACE LEFORT I 2 PIECES W/O BONE GRAFT | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| RCNSTJ MNDBL XTRORAL W/TRANSOSTEAL BONE PLATE | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| RCNSTJ MNDBLR CONDYLE W/BONE CARTLG AUTOGRAFTS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RCNSTJ MNDBLR RAMI&/BDY SGTL SPLT W/INT RGD FI | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RCNSTJ MNDBLR RAMI&/BODY SGTL SPLT W/O INT RGD | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RCNSTJ PLSTC BILIARY DUCTS W/END-TO-END ANAST | 10 (<0.1%) | 7 (<0.1%) | 3 (<0.1%) | |
| RDCTJ VOLVULUS INTUSSUSCEPTION INT HRNA LAPT | 171 (<0.1%) | 122 (<0.1%) | 49 (<0.1%) | |
| RECONSTRUCTION VENA CAVA ANY METHOD | 12 (<0.1%) | 7 (<0.1%) | 5 (<0.1%) | |
| REDUCTION MAMMAPLASTY | 89 (<0.1%) | 89 (<0.1%) | 0 (0%) | |
| REINSERTION SPINAL FIXATION DEVICE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| REMOVAL ANTERIOR INSTRUMENTATION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REMOVAL FOREIGN BODY DEEP THIGH/KNEE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REMOVAL FOREIGN BODY PELVIS/HIP DEEP | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| REMOVAL INTACT MAMMARY IMPLANT | 17 (<0.1%) | 17 (<0.1%) | 0 (0%) | |
| REMOVAL LUNG PNEUMONECTOMY EXTRAPLEURAL | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| REMOVAL LUNG PNEUMONECTOMY RESXN SGMNT TRACHEA | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| REMOVAL MAMMARY IMPLANT MATERIAL | 6 (<0.1%) | 6 (<0.1%) | 0 (0%) | |
| REMOVAL OF LUNG PNEUMONECTOMY | 16 (<0.1%) | 8 (<0.1%) | 8 (<0.1%) | |
| REMOVAL PERITONEAL FOREIGN BODY FROM CAVITY | 72 (<0.1%) | 41 (<0.1%) | 31 (<0.1%) | |
| REMOVAL POSTERIOR NONSEGMENTAL INSTRUMENTATION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REMOVAL POSTERIOR SEGMENTAL INSTRUMENTATION | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| REMOVAL PROSTHETIC MATRL ABDL WALL FOR INFECTION | 167 (<0.1%) | 87 (<0.1%) | 80 (<0.1%) | |
| REMOVAL TUNNELED INTRAPERITONEAL CATHETER | 159 (<0.1%) | 66 (<0.1%) | 93 (<0.1%) | |
| REMVL INFLATABLE URETHRAL/BLADDER NECK SPHINCTER | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RENAL BIOPSY SURG EXPOSURE KIDNEY | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| REOPENING RECENT LAPAROTOMY | 33 (<0.1%) | 20 (<0.1%) | 13 (<0.1%) | |
| REPAIR ANAL FISTULA W/FIBRIN GLUE | 5 (<0.1%) | 4 (<0.1%) | 1 (<0.1%) | |
| REPAIR BLOOD VESSEL DIRECT NECK | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| REPAIR BLOOD VESSEL DIRECT UPPER EXTREMITY | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| REPAIR BLOOD VESSEL VEIN GRAFT INTRA-ABDOMINAL | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| REPAIR BLOOD VESSEL VEIN GRAFT LOWER EXTREMITY | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| REPAIR BLOOD VESSEL W/VEIN GRAFT UPPER EXTREMITY | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| REPAIR ENTEROCELE ABDOMINAL APPROACH SPX | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| REPAIR ENTEROCELE VAGINAL APPROACH SPX | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REPAIR FASCIAL DEFECT LEG | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| REPAIR FIRST ABDOMINAL WALL HERNIA | 14,305 (2.6%) | 7,776 (2.4%) | 6,529 (3.0%) | |
| REPAIR LACERATION DIAPHRAGM ANY APPROACH | 15 (<0.1%) | 11 (<0.1%) | 4 (<0.1%) | |
| REPAIR LUMBAR HERNIA | 48 (<0.1%) | 30 (<0.1%) | 18 (<0.1%) | |
| REPAIR LUNG HERNIA THROUGH CHEST WALL | 10 (<0.1%) | 2 (<0.1%) | 8 (<0.1%) | |
| REPAIR NON/MALUNION HUMERUS W/ILIAC/OTH AGRFT | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| REPAIR PECTUS EXCAVATM/CARINATM MINLY W/O THRSC | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| REPAIR PECTUS EXCAVATM/CARINATM MINLY W/THRSC | 25 (<0.1%) | 7 (<0.1%) | 18 (<0.1%) | |
| REPAIR PECTUS EXCAVATUM/CARINATUM OPEN | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| REPAIR PRIMARY OPEN/PRQ RUPTURED ACHILLES TENDON | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REPAIR RECTOCELE SEPARATE PROCEDURE | 57 (<0.1%) | 56 (<0.1%) | 1 (<0.1%) | |
| REPAIR SECONDARY ACHILLES TENDON W/WO GRAFT | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| REPLACE AORTIC VALVE OPENFEMORAL ARTERY APPROACH | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| REPLACE AORTIC VALVE PERQ FEMORAL ARTRY APPROACH | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| REPLACEMENT MITRAL VALVE W/CARDIOPULMONARY BYP | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| REPSNG INTRVAS VC FILTR W/WO ACS VSL SELXN RS& | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RESCJ APICAL LUNG TUMOR W/CHEST WALL RCNSTJ | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RESCJ APICAL LUNG TUMOR W/O CHEST WALL RCNSTJ | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| RESCJ DIAPHRAGM W/COMPLEX REPAIR | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| RESCJ DIAPHRAGM W/SIMPLE REPAIR | 19 (<0.1%) | 12 (<0.1%) | 7 (<0.1%) | |
| RESCJ OVARIAN/TUBAL/PERITONEAL MALIGNANCY W/BSO | 15 (<0.1%) | 15 (<0.1%) | 0 (0%) | |
| RESCJ PALATE/EXTENSIVE RESCJ LESION | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| RESCJ PRIM PRTL MAL W/BSO & OMNTC RAD DEBULKING | 42 (<0.1%) | 42 (<0.1%) | 0 (0%) | |
| RESCJ PRIM PRTL MAL W/BSO & OMNTC TAH & LMPHAD | 15 (<0.1%) | 15 (<0.1%) | 0 (0%) | |
| RESCJ/EXC LES BASE ANT CRNL FOSSA INDRL W/WO GRF | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RESCJ/EXC LES INFRATEMPOR FOSSA SPACE APEX XDRL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RESECJ RECUR OVARIAN/TUBAL/PERITONEAL MALIGNANCY | 51 (<0.1%) | 41 (<0.1%) | 10 (<0.1%) | |
| RESECJ/DBRDMT PANCREAS NECROTIZING PANCREATITIS | 117 (<0.1%) | 45 (<0.1%) | 72 (<0.1%) | |
| RESECTION MEDIASTINAL TUMOR | 15 (<0.1%) | 9 (<0.1%) | 6 (<0.1%) | |
| RESECTION PERICARDIAL CYST/TUMOR | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| RESECTION RECRT MAL W/OMENTECTOMY PEL LMPHADEC | 10 (<0.1%) | 7 (<0.1%) | 3 (<0.1%) | |
| RESECTION RIBS EXTRAPLEURAL ALL STAGES | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| RESECTION SCROTUM | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| REVASCULARIZATION ILIAC ART ANGIOP EA IPSI VSL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REVASCULARIZATION ILIAC ARTERY ANGIOP 1ST VSL | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| REVIS PERITONEAL-VENOUS SHUNT | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| REVIS SHOULDER ARTHRPLSTY HUMERAL&GLENOID COMPNT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| REVISION FEMORAL ANAST OPEN NONAUTOG GRAFT | 12 (<0.1%) | 7 (<0.1%) | 5 (<0.1%) | |
| REVISION OPEN GASTRIC RESTRICTIVE PX NOT DEVICE | 426 (<0.1%) | 363 (0.1%) | 63 (<0.1%) | |
| REVISION RECONSTRUCTED BREAST | 11 (<0.1%) | 11 (<0.1%) | 0 (0%) | |
| REVJ COLOSTOMY COMP RCNSTJ IN-DEPTH SPX | 276 (<0.1%) | 146 (<0.1%) | 130 (<0.1%) | |
| REVJ COLOSTOMY SMPL RLS SUPFC SCAR SPX | 214 (<0.1%) | 98 (<0.1%) | 116 (<0.1%) | |
| REVJ COLOSTOMY W/RPR PARACLST HERNIA SPX | 814 (0.2%) | 424 (0.1%) | 390 (0.2%) | |
| REVJ GASTRODUOL ANAST W/RCNSTJ W/O VAGOTOMY | 25 (<0.1%) | 24 (<0.1%) | 1 (<0.1%) | |
| REVJ GASTRODUOL ANAST W/RCNSTJ W/VGTMY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REVJ GSTR/JJ ANAST W/RCNSTJ W/O VGTMY | 394 (<0.1%) | 322 (<0.1%) | 72 (<0.1%) | |
| REVJ GSTR/JJ ANAST W/RCNSTJ W/VGTMY | 29 (<0.1%) | 22 (<0.1%) | 7 (<0.1%) | |
| REVJ ILEOSTOMY COMPLIC RCNSTJ IN-DEPTH SPX | 467 (<0.1%) | 245 (<0.1%) | 222 (0.1%) | |
| REVJ ILEOSTOMY SIMPLE RLS SUPERFICIAL SCAR SPX | 405 (<0.1%) | 212 (<0.1%) | 193 (<0.1%) | |
| REVJ LXTR ARTL BYP OPN VEIN PATCH ANGIOP | 7 (<0.1%) | 1 (<0.1%) | 6 (<0.1%) | |
| REVJ LXTR ARTL BYP OPN W/SGMTL VEIN INTERPOS | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| REVJ TOT HIP ARTHRP ACTBLR W/WO AGRFT/ALGRFT | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| REVJ TOT HIP ARTHRP BTH W/WO AGRFT/ALGRFT | 18 (<0.1%) | 11 (<0.1%) | 7 (<0.1%) | |
| REVJ TOT HIP ARTHRP FEM ONLY W/WO ALGRFT | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| REVJ TOT KNEE ARTHRP FEM&ENTIRE TIBIAL COMPONE | 9 (<0.1%) | 5 (<0.1%) | 4 (<0.1%) | |
| REVJ TOTAL KNEE ARTHRP W/WO ALGRFT 1 COMPONENT | 11 (<0.1%) | 6 (<0.1%) | 5 (<0.1%) | |
| REVJ UR-CUTAN ANAST RPR FSCAL DFCT & HERNIA | 17 (<0.1%) | 9 (<0.1%) | 8 (<0.1%) | |
| REVJ URINARY-CUTANEOUS ANASTAMOSIS | 8 (<0.1%) | 2 (<0.1%) | 6 (<0.1%) | |
| REVJ W/RMVL PROSTHETIC VAGINAL GRAFT ABDML APPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REVJ/RMVL INTRACRANIAL NEUROSTIMULATOR ELTRDS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REVSC OPN/PRG FEM/POP W/ANGIOPLASTY UNI | 27 (<0.1%) | 13 (<0.1%) | 14 (<0.1%) | |
| REVSC OPN/PRQ FEM/POP W/ATHRC/ANGIOP SM VSL | 24 (<0.1%) | 8 (<0.1%) | 16 (<0.1%) | |
| REVSC OPN/PRQ FEM/POP W/STNT/ANGIOP SM VSL | 35 (<0.1%) | 15 (<0.1%) | 20 (<0.1%) | |
| REVSC OPN/PRQ FEM/POP W/STNT/ATHRC/ANGIOP SM VSL | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| REVSC OPN/PRQ ILIAC ART W/STNT & ANGIOP IPSILATL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| REVSC OPN/PRQ ILIAC ART W/STNT PLMT & ANGIOPLSTY | 38 (<0.1%) | 14 (<0.1%) | 24 (<0.1%) | |
| REVSC OPN/PRQ TIB/PERO W/ANGIOPLASTY UNI | 12 (<0.1%) | 3 (<0.1%) | 9 (<0.1%) | |
| REVSC OPN/PRQ TIB/PERO W/ATHRC/ANGIOP SM VSL | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| REVSC OPN/PRQ TIB/PERO W/STNT/ATHR/ANGIOP SM VSL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RMVL FOREIGN BODY PELVIS/HIP SUBCUTANEOUS TISS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RMVL LUNG OTH/THN PNUMEC RESXN-PLCTJ EMPHY LUNG | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| RMVL LUNG OTHER THAN PNEUMONECT 1 SEGMENTECTOMY | 25 (<0.1%) | 11 (<0.1%) | 14 (<0.1%) | |
| RMVL LUNG OTHER THAN PNEUMONECT 2 LOBES BILOBEC | 37 (<0.1%) | 18 (<0.1%) | 19 (<0.1%) | |
| RMVL LUNG OTHER THAN PNEUMONECTOMY 1 LOBE LOBECT | 421 (<0.1%) | 230 (<0.1%) | 191 (<0.1%) | |
| RMVL LUNG OTHER/THAN PNUMEC COMPLETION PNUMEC | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| RMVL LUNG XCP TOT PNEUMONECTOMY SLEEVE LOBECTOMY | 5 (<0.1%) | 4 (<0.1%) | 1 (<0.1%) | |
| RMVL PROSTH TOT KNEE PROSTH MMA W/WO INSJ SPACER | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| ROPRTJ > 1 MO AFTER ORIGINAL OPRATION | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| ROPRTJ CRTD TEAEC > 1 MO AFTER ORIGINAL OPRATIO | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| RPLCMT PROST AORTIC VALVE OPEN XCP HOMOGRF/STENT | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| RPLCMT PROST AORTIC VALVE XCP HOMOGRF/STENT | 6 (<0.1%) | 2 (<0.1%) | 4 (<0.1%) | |
| RPR 1ST FEM HERNIA ANY AGE INCARCERATED | 52 (<0.1%) | 39 (<0.1%) | 13 (<0.1%) | |
| RPR 1ST FEM HRNA ANY AGE REDUCIBLE | 88 (<0.1%) | 68 (<0.1%) | 20 (<0.1%) | |
| RPR 1ST INCAL/VNT HERNIA INCARCERATED | 4,290 (0.8%) | 2,563 (0.8%) | 1,727 (0.8%) | |
| RPR 1ST INGUN HRNA AGE 5 YRS/> INCARCERATED | 623 (0.1%) | 52 (<0.1%) | 571 (0.3%) | |
| RPR 1ST INGUN HRNA AGE 5 YRS/> REDUCIBLE | 3,222 (0.6%) | 291 (<0.1%) | 2,931 (1.4%) | |
| RPR BLOOD VESSEL DIRECT INTRA-ABDOMINAL | 17 (<0.1%) | 7 (<0.1%) | 10 (<0.1%) | |
| RPR BLOOD VESSEL DIRECT INTRATHORACIC W/O BYPASS | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| RPR BLOOD VESSEL DIRECT LOWER EXTREMITY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR BLVSL W/GRF OTHER/THAN VEIN LOWER EXTREMITY | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| RPR BLVSL W/GRFT OTHER/THAN VEIN INTRA-ABDOMINAL | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| RPR CLOACAL ANOMALY CMBN ABDL & SACROPRNL W/GRF | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR CLOACAL ANOMALY CMBN ABDL&SACROPRNL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR CLOACAL ANOMALY SACROPERINEAL | 5 (<0.1%) | 5 (<0.1%) | 0 (0%) | |
| RPR DIPHRG HRNA OTH/THN NEONATAL TRAUMTC AQT | 21 (<0.1%) | 6 (<0.1%) | 15 (<0.1%) | |
| RPR DIPHRG HRNA OTH/THN NEONATAL TRAUMTC CHRNC | 61 (<0.1%) | 32 (<0.1%) | 29 (<0.1%) | |
| RPR DURAL/CEREBROSPINAL FLUID LEAK X REQ LAM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RPR DURAL/CSF LEAK/PSEUDOMENINGOCELE W/LAM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR EPIGASTRIC HERNIA INCARCERATED | 76 (<0.1%) | 42 (<0.1%) | 34 (<0.1%) | |
| RPR EPIGASTRIC HERNIA REDUCIBLE SPX | 212 (<0.1%) | 112 (<0.1%) | 100 (<0.1%) | |
| RPR HI IMPRF ANUS W/FSTL PRNL/SACROPRNL APPR | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR HI IMPRF ANUS W/FSTL TABDL & SACROPRNL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR ILEOANAL POUCH FSTL/POUCH ADVMNT CMBN APPR | 15 (<0.1%) | 11 (<0.1%) | 4 (<0.1%) | |
| RPR ILEOANAL POUCH FSTL/POUCH ADVMNT TPRNL APPR | 12 (<0.1%) | 9 (<0.1%) | 3 (<0.1%) | |
| RPR INGUN HERNIA SLIDING ANY AGE | 166 (<0.1%) | 17 (<0.1%) | 149 (<0.1%) | |
| RPR LG OMPHALOCELE/GASTROSCHISIS W/WO PROSTH | 6 (<0.1%) | 4 (<0.1%) | 2 (<0.1%) | |
| RPR NEONATAL DIPHRG HERNIA W/WO CHEST TUBE INSJ | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| RPR NON/MAL FEMUR DSTL H/N W/O GRF | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RPR NON/MAL TIBIA SYNOSTOSIS W/FIBULA ANY METH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RPR NON/MAL TIBIA W/ILIAC/OTH AGRFT | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RPR NONUNION/MALUNION RADIUS/ULNA W/AUTOGRAFT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR NONUNION/MALUNION RADIUS/ULNA W/O AUTOGRAFT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| RPR PARAESOPH HIATAL HERNIA THORCOABDOM W/MESH | 16 (<0.1%) | 9 (<0.1%) | 7 (<0.1%) | |
| RPR PARAESOPH HIATAL HERNIA THORCOABDOM W/O MESH | 24 (<0.1%) | 18 (<0.1%) | 6 (<0.1%) | |
| RPR PARAESOPH HIATAL HERNIA W/LAPT W/O MESH | 413 (<0.1%) | 295 (<0.1%) | 118 (<0.1%) | |
| RPR PARAESOPH HIATAL HERNIA W/THORCOM W/MESH | 5 (<0.1%) | 4 (<0.1%) | 1 (<0.1%) | |
| RPR PARAESOPH HIATAL HERNIA W/THORCOM W/O MESH | 18 (<0.1%) | 11 (<0.1%) | 7 (<0.1%) | |
| RPR RECRT FEM HERNIA REDUCIBLE | 15 (<0.1%) | 13 (<0.1%) | 2 (<0.1%) | |
| RPR RECRT FEM HRNA INCARCERATED | 10 (<0.1%) | 7 (<0.1%) | 3 (<0.1%) | |
| RPR RECRT INCAL/VNT HERNIA INCARCERATED | 2,560 (0.5%) | 1,528 (0.5%) | 1,032 (0.5%) | |
| RPR RECRT INCAL/VNT HERNIA REDUCIBLE | 5,506 (1.0%) | 3,095 (1.0%) | 2,411 (1.1%) | |
| RPR RECRT INGUINAL HERNIA ANY AGE REDUCIBLE | 408 (<0.1%) | 28 (<0.1%) | 380 (0.2%) | |
| RPR RECRT INGUN HERNIA ANY AGE INCARCERATED | 163 (<0.1%) | 12 (<0.1%) | 151 (<0.1%) | |
| RPR RPTD SPLEEN SPLENORRHAPHY W/WO PRTL SPLENECT | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| RPR SMALL OMPHALOCELE W/PRIMARY CLOSURE | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| RPR SPIGELIAN HERNIA | 100 (<0.1%) | 65 (<0.1%) | 35 (<0.1%) | |
| RPR TABDL LMPHADEC EXTNSV W/PEL AORTIC&RNL | 56 (<0.1%) | 29 (<0.1%) | 27 (<0.1%) | |
| RPR THORACOABDOMINAL AORTIC ANEURYS W/WO BYPASS | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| RPR UMBILICAL HERNIA < 5 YRS INCARCERATED | 9 (<0.1%) | 2 (<0.1%) | 7 (<0.1%) | |
| RPR UMBILICAL HERNIA < 5 YRS REDUCIBLE | 25 (<0.1%) | 11 (<0.1%) | 14 (<0.1%) | |
| RPR UMBILICAL HERNIA AGE 5 YRS/> INCARCERATED | 903 (0.2%) | 361 (0.1%) | 542 (0.3%) | |
| RPR UMBILICAL HRNA 5 YRS/> REDUCIBLE | 2,443 (0.5%) | 934 (0.3%) | 1,509 (0.7%) | |
| RPR/ADVMNT FLXR TDN N/Z/2 W/O FR GRAFT EA TENDON | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RPR/ADVMNT FLXR TDN ZONE 2 W/O FR GRFT EA TENDON | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| RPR/TRAUMATIC AV FISTULA EXTREMITIES | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| SALPINGECTOMY COMPLETE/PARTIAL UNI/BI SPX | 9 (<0.1%) | 9 (<0.1%) | 0 (0%) | |
| SALPINGO-OOPHORECTOMY COMPL/PRTL UNI/BI SPX | 57 (<0.1%) | 56 (<0.1%) | 1 (<0.1%) | |
| SALPINGOSTOMY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| SCROTAL EXPLORATION | 3 (<0.1%) | 0 (0%) | 3 (<0.1%) | |
| SCROTOPLASTY COMPLICATED | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| SCROTOPLASTY SIMPLE | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| SEC ABDOMINAL WALL SUTURE EVISCERATION/DEHSN | 15 (<0.1%) | 7 (<0.1%) | 8 (<0.1%) | |
| SLING OPERATION STRESS INCONTINENCE | 7 (<0.1%) | 7 (<0.1%) | 0 (0%) | |
| SPHINCTEROPLASTY ANAL MUSCLE TRANSPLANT | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| SPHNCTROP ANAL IMPLTJ ARTIF SPHNCTR | 12 (<0.1%) | 9 (<0.1%) | 3 (<0.1%) | |
| SPHNCTROP ANAL INCONTINENCE/PROLAPSE ADULT | 88 (<0.1%) | 80 (<0.1%) | 8 (<0.1%) | |
| SPHNCTROP ANAL LEVATOR MUSC IMBRCJ | 16 (<0.1%) | 16 (<0.1%) | 0 (0%) | |
| SPLENC TOT EN BLOC EXTNSV DS CONJUNCT W/OTH PX | 50 (<0.1%) | 30 (<0.1%) | 20 (<0.1%) | |
| SPLENECTOMY TOTAL EN BLOC W/OTHER PROCEDURE | 17 (<0.1%) | 14 (<0.1%) | 3 (<0.1%) | |
| SPLENECTOMY TOTAL SEPARATE PROCEDURE | 631 (0.1%) | 304 (<0.1%) | 327 (0.2%) | |
| STAB PHLEBT VARICOSE VEINS 1 XTR 10-20 STAB INCS | 7 (<0.1%) | 6 (<0.1%) | 1 (<0.1%) | |
| STAGING LAPAROTOMY HODGKINS DISEASE/LYMPHOMA | 11 (<0.1%) | 4 (<0.1%) | 7 (<0.1%) | |
| SUB GRFT F/S/N/H/F/G/M/D </= 100SCM 1ST 100SQ CM | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| SUB GRFT F/S/N/H/F/G/M/D <100SQ CM 1ST 25 SQ CM | 19 (<0.1%) | 11 (<0.1%) | 8 (<0.1%) | |
| SUB GRFT F/S/N/H/F/G/M/D >/= 100SCM 1ST 100SQ CM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| SUPRACERVICAL ABDL HYSTER W/WO RMVL TUBE OVARY | 46 (<0.1%) | 46 (<0.1%) | 0 (0%) | |
| SUPRAHYOID LYMPHADENECTOMY | 7 (<0.1%) | 2 (<0.1%) | 5 (<0.1%) | |
| SURG CLSR TRACHEOSTOMY/FISTULA W/O PLASTIC RPR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| SUTR ESOPHGL WND/INJ CRV APPR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| SUTR ESOPHGL WND/INJ TTHRC/TABDL APPR | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| SUTR LG INTESTINE 1/MULT PERFORAT W/COLOSTOMY | 9 (<0.1%) | 7 (<0.1%) | 2 (<0.1%) | |
| SUTR LG INTESTINE 1/MULT PERFORAT W/O COLOSTOMY | 54 (<0.1%) | 36 (<0.1%) | 18 (<0.1%) | |
| SUTR RPR AORTA/GRT VSL W/O SHUNT/CARD BYP | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| SUTURE EXTRAHEPATIC BILE DUCT PRE-EXIST INJURY | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| SUTURE MESENTERY SEPARATE PROCEDURE | 6 (<0.1%) | 5 (<0.1%) | 1 (<0.1%) | |
| SUTURE TRACHEAL WOUND/INJURY CERVICAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| SYMPATHECTOMY LUMBAR | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| SYMPATHECTOMY THORACOLUMBAR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| TCAT IV STENT CRV CRTD ART EMBOLIC PROTECJ | 14 (<0.1%) | 4 (<0.1%) | 10 (<0.1%) | |
| TCAT IV STENT CRV CRTD ART W/O EMBOLIC PROTECJ | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| TDN TRNSPLJ/TR FLXR/XTNSR F/ARM&/WRST 1 EA TDN | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| TEAEC W/GRAFT POPLITEAL ARTERY | 18 (<0.1%) | 4 (<0.1%) | 14 (<0.1%) | |
| TEAEC W/GRAFT SUPERFICIAL FEMORAL ARTERY | 50 (<0.1%) | 18 (<0.1%) | 32 (<0.1%) | |
| TEAEC W/GRAFT TIBIAL/PERONEAL ART 1ST VESSEL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| TEAEC W/PATCH GRF CAROTID VERTB SUBCLAV NECK INC | 1,554 (0.3%) | 625 (0.2%) | 929 (0.4%) | |
| TEAEC W/WO PATCH GRAFT ABDOMINAL AORTA | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| TEAEC W/WO PATCH GRAFT COMBINED AORTOILIOFEMORAL | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| TEAEC W/WO PATCH GRAFT COMMON FEMORAL | 142 (<0.1%) | 45 (<0.1%) | 97 (<0.1%) | |
| TEAEC W/WO PATCH GRAFT DEEP PROFUNDA FEMORAL | 35 (<0.1%) | 9 (<0.1%) | 26 (<0.1%) | |
| TEAEC W/WO PATCH GRAFT ILIAC | 19 (<0.1%) | 4 (<0.1%) | 15 (<0.1%) | |
| TEAEC W/WO PATCH GRAFT ILIOFEMORAL | 27 (<0.1%) | 8 (<0.1%) | 19 (<0.1%) | |
| TEAEC W/WO PATCH GRF AXILLARY-BRACHIAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TENOTOMY ADDUCTOR HIP OPEN | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| THORACOP SCHEDE TYP/XTRPLEURAL CLSR BRNCPLR FSTL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| THORACOPLASTY SCHEDE TYPE/EXTRAPLEURAL | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| THORACOSCOPY CONTROL TRAUMATIC HEMORRHAGE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| THORACOSCOPY RESEXN THYMUS UNI/BILATERAL | 20 (<0.1%) | 12 (<0.1%) | 8 (<0.1%) | |
| THORACOSCOPY RMVL INTRAPLEURAL FB/FIBRIN DEPOSIT | 6 (<0.1%) | 0 (0%) | 6 (<0.1%) | |
| THORACOSCOPY W/BILOBECTOMY | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| THORACOSCOPY W/DX BX OF LUNG INFILTRATE UNILATRL | 97 (<0.1%) | 39 (<0.1%) | 58 (<0.1%) | |
| THORACOSCOPY W/DX BX OF LUNG NODULES UNILATRL | 146 (<0.1%) | 78 (<0.1%) | 68 (<0.1%) | |
| THORACOSCOPY W/DX WEDGE RESEXN ANATO LUNG RESEXN | 59 (<0.1%) | 29 (<0.1%) | 30 (<0.1%) | |
| THORACOSCOPY W/ESOPHAGOMYOTOMY HELLER TYPE | 18 (<0.1%) | 8 (<0.1%) | 10 (<0.1%) | |
| THORACOSCOPY W/EXC MEDIASTINAL CYST TUMOR/MASS | 36 (<0.1%) | 18 (<0.1%) | 18 (<0.1%) | |
| THORACOSCOPY W/EXC PERICARDIAL CYST TUMOR/MASS | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| THORACOSCOPY W/LOBECTOMY SINGLE LOBE | 675 (0.1%) | 412 (0.1%) | 263 (0.1%) | |
| THORACOSCOPY W/PARIETAL PLEURECTOMY | 6 (<0.1%) | 4 (<0.1%) | 2 (<0.1%) | |
| THORACOSCOPY W/PARTIAL PULMONARY DECORTICATION | 50 (<0.1%) | 16 (<0.1%) | 34 (<0.1%) | |
| THORACOSCOPY W/PLEURODESIS | 88 (<0.1%) | 41 (<0.1%) | 47 (<0.1%) | |
| THORACOSCOPY W/PNEUMONECTOMY | 8 (<0.1%) | 2 (<0.1%) | 6 (<0.1%) | |
| THORACOSCOPY W/RESECTION BULLAE W/WO PLEURAL PX | 30 (<0.1%) | 11 (<0.1%) | 19 (<0.1%) | |
| THORACOSCOPY W/RESEXN-PLICAJ EMPHYSEMA LUNG UNIL | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| THORACOSCOPY W/SEGMENTECTOMY | 75 (<0.1%) | 51 (<0.1%) | 24 (<0.1%) | |
| THORACOSCOPY W/THERA WEDGE RESEXN ADDL IPSILATRL | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| THORACOSCOPY W/THERA WEDGE RESEXN INITIAL UNILAT | 458 (<0.1%) | 235 (<0.1%) | 223 (0.1%) | |
| THORACOSCOPY W/THORACIC SYMPATHECTOMY | 11 (<0.1%) | 3 (<0.1%) | 8 (<0.1%) | |
| THORACOSCOPY WITH BIOPSYIES OF PLEURA | 49 (<0.1%) | 15 (<0.1%) | 34 (<0.1%) | |
| THORACOSTOMY OPEN FLAP DRAINAGE EMPYEMA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| THORACOSTOMY W/RIB RESECTION EMPYEMA | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| THORACOTOMY OPN INTRAPLEURAL PNEUMONOLYSIS | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| THORACOTOMY POSTOPERATIVE COMPLICATIONS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| THORACOTOMY W/BIOPSY OF PLEURA | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| THORACOTOMY W/DX WEDGE RESEXN & ANTOM LUNG RESE | 8 (<0.1%) | 5 (<0.1%) | 3 (<0.1%) | |
| THORACOTOMY W/RESECTION BULLAE | 5 (<0.1%) | 3 (<0.1%) | 2 (<0.1%) | |
| THORACOTOMY W/THERAPEUTIC WEDGE RESEXN INITIAL | 84 (<0.1%) | 40 (<0.1%) | 44 (<0.1%) | |
| THORACOTOMY WITH EXPLORATION | 21 (<0.1%) | 10 (<0.1%) | 11 (<0.1%) | |
| THORACTOMY W/DX BX LUNG INFILTRATE UNILATERAL | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| THORACTOMY W/DX BX LUNG NODULE/MASS UNILATERAL | 20 (<0.1%) | 7 (<0.1%) | 13 (<0.1%) | |
| THORCOM CTRL TRAUMTC HEMRRG&/RPR LNG TEAR | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| THORCOM THRC W/MEDSTNL & REGIONAL LMPHADEC | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| THORCOM W/REMOVAL OF CYST | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| THORCOM W/RMVL INTRAPLEURAL FB/FIBRIN DEP | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| THORCOM W/RMVL IPUL FB | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| THORCOSCPY W/MEDIASTINL & REGIONL LYMPHDENECTOMY | 20 (<0.1%) | 12 (<0.1%) | 8 (<0.1%) | |
| THRMBC ARTL/VEN GRF OTH/THN HEMO GRF/FSTL | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| THRMBC ARTL/VEN GRF XCP HEMO GRF/FSTL W/REVJ GRF | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| THRMBC DIR/W/CATH AXILL&SUBCLAVIAN VEIN ARM IN | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| THRMBC DIR/W/CATH SUBCLAVIAN VEIN NECK INC | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| THRMBC DIR/W/CATH V/C ILIAC FEMPOP VEIN ABDL&LEG | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| THRMBC DIR/W/CATH V/C ILIAC FEMPOP VEIN LEG INC | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| THRMBC DIR/W/CATH VENA CAVA ILIAC VEIN ABDL INC | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| THRSC CRTJ PRCRD WINDOW/PRTL RESCJ PRCRD SAC | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| THRSC TOT PULM DCRTCTJ INTRAPLEURAL PNEUMONOLSS | 30 (<0.1%) | 11 (<0.1%) | 19 (<0.1%) | |
| THYMECTOMY PRTL/TOT RAD MEDSTNL DSJ SPX | 9 (<0.1%) | 3 (<0.1%) | 6 (<0.1%) | |
| THYMECTOMY PRTL/TOT TRANSCERVICAL APPR SPX | 43 (<0.1%) | 24 (<0.1%) | 19 (<0.1%) | |
| THYMECTOMY PRTL/TOT W/O RAD MEDSTNL DSJ SPX | 19 (<0.1%) | 12 (<0.1%) | 7 (<0.1%) | |
| THYROIDECT W/SUBSTERNAL SPLIT/TRANSTHORACIC | 74 (<0.1%) | 56 (<0.1%) | 18 (<0.1%) | |
| THYROIDECTOMY RMVL REMAINING TISS FLWG PRTL RMVL | 367 (<0.1%) | 280 (<0.1%) | 87 (<0.1%) | |
| THYROIDECTOMY SUBSTERNAL CERVICAL APPROACH | 319 (<0.1%) | 241 (<0.1%) | 78 (<0.1%) | |
| THYROIDECTOMY TOTAL/COMPLETE | 5,024 (0.9%) | 4,045 (1.2%) | 979 (0.5%) | |
| THYROIDECTOMY TOTAL/SUBTOTAL LMTD NECK DISSECT | 1,285 (0.2%) | 956 (0.3%) | 329 (0.2%) | |
| THYROIDECTOMY TOTAL/SUBTOTAL RAD NECK DISSECT | 329 (<0.1%) | 208 (<0.1%) | 121 (<0.1%) | |
| TISSUE GRAFTS OTHER | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| TONSILLECTOMY & ADENOIDECTOMY AGE 12/> | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TONSILLECTOMY ONE-HALF AGE 12/> | 9 (<0.1%) | 4 (<0.1%) | 5 (<0.1%) | |
| TONSILLECTOMY PRIMARY/SECONDARY AGE 12/> | 7 (<0.1%) | 4 (<0.1%) | 3 (<0.1%) | |
| TOT ABD HYST W/PARAORTIC & PELVIC LYMPH NODE SAM | 10 (<0.1%) | 10 (<0.1%) | 0 (0%) | |
| TOT ABD HYST W/WO RMVL TUBE OVARY W/COLPURETHRXY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TOT DISC ARTHRP ANT APPR DISC 2ND LEVEL CERVICAL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TOT DISC ARTHRP ART DISC ANT APPRO 1 NTRSPC CRV | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| TOT DISC ARTHRP ART DISC ANT APPRO 1 NTRSPC LMBR | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| TOT ESOPHAGECTOMY W/O THORCOM W/WO PYLOROPLASTY | 753 (0.1%) | 122 (<0.1%) | 631 (0.3%) | |
| TOT ESOPHG W/O THORCOM COLON NTRPSTJ/INT RCNSTJ | 12 (<0.1%) | 5 (<0.1%) | 7 (<0.1%) | |
| TOT ESOPHG W/THORCOM W/COLON NTRPSTJ/INT RCNSTJ | 20 (<0.1%) | 6 (<0.1%) | 14 (<0.1%) | |
| TOT/PRTL ESPHG W/O RCNSTJ W/CRV ESOPHAGOSTOMY | 46 (<0.1%) | 8 (<0.1%) | 38 (<0.1%) | |
| TOTAL ABDOMINAL HYSTERECT W/WO RMVL TUBE OVARY | 319 (<0.1%) | 318 (<0.1%) | 1 (<0.1%) | |
| TOTAL ESOPHAGECTOMY W/THORCOM W/WO PYLORPLASTY | 374 (<0.1%) | 62 (<0.1%) | 312 (0.1%) | |
| TOTAL THYROID LOBEC UNI W/CONTRALAT STOT LOBEC | 146 (<0.1%) | 117 (<0.1%) | 29 (<0.1%) | |
| TOTAL THYROID LOBECTOMY UNI W/WO ISTHMUSECTOMY | 2,021 (0.4%) | 1,556 (0.5%) | 465 (0.2%) | |
| TRACHELECTOMY CERVICECTOMY AMP CERVIX SPX | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TRACHEOPLASTY INTRATHORACIC | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| TRANSDUOL SPHINCTEROT/PLASTY W/WO RMVL CALCULUS | 25 (<0.1%) | 24 (<0.1%) | 1 (<0.1%) | |
| TRANSFER ANY PEDICLE FLAP ANY LOCATION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TRANSFER/TRANSPLANT TENDON PALMAR W/GRAFT EACH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| TRANSPEDICULAR DCMPRN SPINAL CORD 1 SEG LUMBAR | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| TRANSPLANTATION TESTIS TO THIGH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| TRANSRECTAL DRAINAGE OF PELVIC ABSCESS | 7 (<0.1%) | 3 (<0.1%) | 4 (<0.1%) | |
| TRANSURETHRAL RESECTION BLADDER NECK | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| TRNSXJ ESOPH W/RPR ESOPHAGEAL VARICES | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TRPOS&/RIMPLTJ SUBCLAVIAN CAROTID ART | 4 (<0.1%) | 1 (<0.1%) | 3 (<0.1%) | |
| TRURL ELECTROSURG RESCJ PROSTATE BLEED COMPLETE | 52 (<0.1%) | 0 (0%) | 52 (<0.1%) | |
| TRURL RESCJ RESIDUAL/REGROWTH OBSTR PRSTATE TISS | 4 (<0.1%) | 0 (0%) | 4 (<0.1%) | |
| TX HUMRAL SHAFT FX W/INSJ IMED IMPLT W/W CERCLGE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| TX INTER/PR/SUBTRCHNTRIC FEM FX IMED IMPLTSCREW | 8 (<0.1%) | 6 (<0.1%) | 2 (<0.1%) | |
| TX INTER/PR/SUBTRCHNTRIC FEMORAL FX SCREW IMPLT | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| TX TIBL SHFT FX IMED IMPLT W/WO SCREWS&/CERCLA | 3 (<0.1%) | 1 (<0.1%) | 2 (<0.1%) | |
| TYMPANOPLASTY W/O MASTOIDECT W/O OSSICLE RECNSTJ | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| U-TUBE HEPATICOENTEROSTOMY | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| UMBILECTOMY OMPHALECTOMY EXC UMBILICUS SPX | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| UNLIS LAPAROSCOPIC PROCEDURE LIVER | 1,033 (0.2%) | 621 (0.2%) | 412 (0.2%) | |
| UNLIS LAPS PX HRNAP HERNIORRHAPHY HERNIOTOMY | 230 (<0.1%) | 142 (<0.1%) | 88 (<0.1%) | |
| UNLISTED LAPAROSCOPIC PROCEDURE ESOPHAGUS | 282 (<0.1%) | 122 (<0.1%) | 160 (<0.1%) | |
| UNLISTED LAPAROSCOPIC PROCEDURE STOMACH | 2,746 (0.5%) | 1,913 (0.6%) | 833 (0.4%) | |
| UNLISTED LAPAROSCOPIC PX ABD PERTONEUM & OMENTUM | 432 (<0.1%) | 245 (<0.1%) | 187 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE APPENDIX | 18 (<0.1%) | 10 (<0.1%) | 8 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE BILIARY TRACT | 38 (<0.1%) | 17 (<0.1%) | 21 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE BLADDER | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE ENDOCRINE SYSTEM | 10 (<0.1%) | 8 (<0.1%) | 2 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE RECTUM | 136 (<0.1%) | 68 (<0.1%) | 68 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE RENAL | 4 (<0.1%) | 3 (<0.1%) | 1 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE SPLEEN | 53 (<0.1%) | 38 (<0.1%) | 15 (<0.1%) | |
| UNLISTED LAPAROSCOPY PROCEDURE UTERUS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| UNLISTED LAPAROSCOPY PX INTESTINE XCP RECTUM | 459 (<0.1%) | 280 (<0.1%) | 179 (<0.1%) | |
| UNLISTED LAPAROSCOPY PX LYMPHATIC SYSTEM | 36 (<0.1%) | 18 (<0.1%) | 18 (<0.1%) | |
| UNLISTED PROCEDURE ABDOMEN PERITONEUM & OMENTUM | 108 (<0.1%) | 61 (<0.1%) | 47 (<0.1%) | |
| UNLISTED PROCEDURE ANUS | 24 (<0.1%) | 10 (<0.1%) | 14 (<0.1%) | |
| UNLISTED PROCEDURE ARTHROSCOPY | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| UNLISTED PROCEDURE BILIARY TRACT | 33 (<0.1%) | 13 (<0.1%) | 20 (<0.1%) | |
| UNLISTED PROCEDURE BREAST | 13 (<0.1%) | 13 (<0.1%) | 0 (0%) | |
| UNLISTED PROCEDURE DIAPHRAGM | 40 (<0.1%) | 26 (<0.1%) | 14 (<0.1%) | |
| UNLISTED PROCEDURE ENDOCRINE SYSTEM | 12 (<0.1%) | 10 (<0.1%) | 2 (<0.1%) | |
| UNLISTED PROCEDURE EXCISION PRESSURE ULCER | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| UNLISTED PROCEDURE FEMUR/KNEE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| UNLISTED PROCEDURE HEMIC OR LYMPHATIC SYSTEM | 27 (<0.1%) | 21 (<0.1%) | 6 (<0.1%) | |
| UNLISTED PROCEDURE LEG/ANKLE | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| UNLISTED PROCEDURE LIVER | 50 (<0.1%) | 30 (<0.1%) | 20 (<0.1%) | |
| UNLISTED PROCEDURE LUNGS & PLEURA | 23 (<0.1%) | 9 (<0.1%) | 14 (<0.1%) | |
| UNLISTED PROCEDURE MALE GENITAL SYSTEM | 4 (<0.1%) | 0 (0%) | 4 (<0.1%) | |
| UNLISTED PROCEDURE MEDIASTINUM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| UNLISTED PROCEDURE MUSCSKELETAL SYSTEM GENERAL | 5 (<0.1%) | 2 (<0.1%) | 3 (<0.1%) | |
| UNLISTED PROCEDURE NECK/THORAX | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| UNLISTED PROCEDURE PANCREAS | 1,062 (0.2%) | 603 (0.2%) | 459 (0.2%) | |
| UNLISTED PROCEDURE PELVIS/HIP JOINT | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| UNLISTED PROCEDURE RECTUM | 127 (<0.1%) | 71 (<0.1%) | 56 (<0.1%) | |
| UNLISTED PROCEDURE SHOULDER | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| UNLISTED PROCEDURE SMALL INTESTINE | 82 (<0.1%) | 48 (<0.1%) | 34 (<0.1%) | |
| UNLISTED PROCEDURE STOMACH | 202 (<0.1%) | 136 (<0.1%) | 66 (<0.1%) | |
| UNLISTED PROCEDURE TRACHEA BRONCHI | 6 (<0.1%) | 5 (<0.1%) | 1 (<0.1%) | |
| UNLISTED PROCEDURE URINARY SYSTEM | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| UNLISTED PROCEDURE VASCULAR SURGERY | 47 (<0.1%) | 25 (<0.1%) | 22 (<0.1%) | |
| UNLISTED PX ABDOMEN MUSCULOSKELETAL SYSTEM | 33 (<0.1%) | 17 (<0.1%) | 16 (<0.1%) | |
| UNLISTED PX MECKEL'S DIVERTICULUM & MESENTERY | 11 (<0.1%) | 5 (<0.1%) | 6 (<0.1%) | |
| URETEROCOLON CONDUIT INTESTINE ANASTOMOSIS | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| URETEROILEAL CONDUIT W/INTESTINE ANASTOMOSIS | 6 (<0.1%) | 3 (<0.1%) | 3 (<0.1%) | |
| URETEROLYSIS W/WORPSG URETER RETROPERIT FIBROSIS | 15 (<0.1%) | 5 (<0.1%) | 10 (<0.1%) | |
| URETERONEOCYSTOSTOMY ANAST 1 URETER BLADDER | 12 (<0.1%) | 2 (<0.1%) | 10 (<0.1%) | |
| URETERORRHAPHY SUTURE URETER SEPARATE PROCEDURE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| URETEROSIGMOIDOSTOMY W/SIGMOID BLADDER & COLOSTO | 4 (<0.1%) | 2 (<0.1%) | 2 (<0.1%) | |
| URETEROURETEROSTOMY | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| URETHRECTOMY TOT W/CYSTOST MALE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| URETHROPLASTY 1 STG RECNST MALE ANTERIOR URETHRA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| URETRECECTOMY W/BLADDER CUFF SEPARATE PROCEDURE | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| URINARY UNIDIVERSION | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| URTROLITHOTOMY MIDDLE ONE-THIRD URETER | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| URTRONEOCSTOST W/VESICO-PSOAS HITCH/BLDR FLAP | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| UTERINE SUSPENSION W/WO SHORTENING LIGAMENTS SPX | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| UVULECTOMY EXCISION UVULA | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| VAG HYST > 250 GM RMVL TUBE&/OVARY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAG HYST > 250 GM RMVL TUBE&/OVARY W/RPR ENTRCLE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAG HYST 250 GM/< W/COLPO-URTCSTOPEXY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAG HYST 250 GM/< W/RMVL TUBE OVARY W/RPR NTRCL | 3 (<0.1%) | 3 (<0.1%) | 0 (0%) | |
| VAG HYST 250 GM/< W/RMVL TUBE&/OVARY | 23 (<0.1%) | 23 (<0.1%) | 0 (0%) | |
| VAG HYSTER W/TOT/PRTL VAGINECT W/RPR ENTEROCELE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAGINAL HYSTERECTOMY >250 GM RPR ENTEROCELE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAGINAL HYSTERECTOMY 250 GM/< W/RPR ENTEROCELE | 3 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) | |
| VAGINAL HYSTERECTOMY RADICAL SCHAUTA OPERATION | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAGINAL HYSTERECTOMY UTERUS > 250 GM | 7 (<0.1%) | 7 (<0.1%) | 0 (0%) | |
| VAGINAL HYSTERECTOMY UTERUS 250 GM/< | 32 (<0.1%) | 32 (<0.1%) | 0 (0%) | |
| VAGINAL HYSTERECTOMY W/TOT/PRTL VAGINECTOMY | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| VAGINECTOMY COMPL RMVL VAG WALL & PARAVAG TISS | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VAGINECTOMY PARTIAL REMOVAL VAGINAL WALL | 7 (<0.1%) | 7 (<0.1%) | 0 (0%) | |
| VAGINECTOMY PRTL RMVL VAG WALL & PARAVAGINAL T | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| VAGOTOMY PFRMD W/PRTL DSTL GSTRCT | 15 (<0.1%) | 11 (<0.1%) | 4 (<0.1%) | |
| VCRPEC LES 1 SEG XDRL LMBR/SAC TRANSPRTL/RPR | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| VCRPEC THORACOLMBR DCMPRN LWR THRC/LMBR 1 SEG | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VCRPEC TRANSPRTL/RPR DCMPRN THRC LMBR/SAC 1 SEG | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| VENOUS ANASTOMOSIS OPEN CAVAL-MESENTERIC | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| VENOUS ANASTOMOSIS OPEN SPLENORENAL PROXIMAL | 2 (<0.1%) | 0 (0%) | 2 (<0.1%) | |
| VERTEBRAL CORPECTOMY ANT DCMPRN CERVICAL 1 SEG | 9 (<0.1%) | 7 (<0.1%) | 2 (<0.1%) | |
| VERTEBRAL CORPECTOMY DCMPRN CERVICAL EA SEG | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| VESICULECTOMY ANY APPROACH | 1 (<0.1%) | 0 (0%) | 1 (<0.1%) | |
| VGTMY W/PYLOROPLASTY W/WO GASTROST PARIETAL CELL | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VGTMY W/PYLORPLSTY W/WO GASTROST TRUNCAL/SLCTV | 30 (<0.1%) | 18 (<0.1%) | 12 (<0.1%) | |
| VLVP MITRAL VALVE W/CARD BYP W/PROSTC RING | 2 (<0.1%) | 1 (<0.1%) | 1 (<0.1%) | |
| VULVECTOMY RAD COMPL BI INGUINOFEM LMPHADECTOMY | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VULVECTOMY RAD PRTL BI INGUINOFEM LMPHADECTOMY | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| VULVECTOMY RAD PRTL UNI INGUINOFEM LMPHADECTOMY | 2 (<0.1%) | 2 (<0.1%) | 0 (0%) | |
| VULVECTOMY RADICAL PARTIAL | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| VULVECTOMY SIMPLE COMPLETE | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | |
| VULVECTOMY SIMPLE PARTIAL | 4 (<0.1%) | 4 (<0.1%) | 0 (0%) | |
| XTRORAL I&D ABSC CST/HMTMA FLOOR MOUTH SUBMNDB | 8 (<0.1%) | 3 (<0.1%) | 5 (<0.1%) | |
|
1
Statistics presented: n (%)
2
Statistical tests performed:
|
||||